Section 47

EurekaMag Full Text Articles Chapter 46,308


Stewart, B.J.; Wardle, S.J.; Haniford, D.B. 2002: IHF-independent assembly of the Tn10 strand transfer transpososome: implications for inhibition of disintegration. Embo Journal 21(16): 4380-4390
Voelker, R. 1997: IHI views collaboration vs competition in quality. Institute for Healthcare Improvement. JAMA 278(19): 1560
Grabeel, J. 1996: IHPs revisited. Journal of School Nursing: the Official Publication of the National Association of School Nurses 12(4): 28-30
Pallarito, K. 1993: IHS CEO planning new nursing home company. Modern Healthcare 23(51): 18; 20
Olesen, J. 1993: IHS Classification: present and future. Cephalalgia: An International Journal of Headache 13(Suppl 12): 94
Saphir, A. 2000: IHS expansion leads to Chapter 11. Modern Healthcare 30(6): 3 12
Anonymous 2002: IHS getting healthy returns in statewide diabetes initiative. Disease Management Advisor 8(6): 85-9 81
Shriver, K. 1996: IHS reports fourth-quarter shortfall. Modern Healthcare 26(10): 73
Doyle, J.M. 1999: IHS takes over NovaCare's contract therapy business. Provider 25(8): 13
Vickery, K. 2001: IHS' reorganization plan taking shape. Provider 27(8): 16
Nichol, D.K. 1984: IHSA Presidential Address 1984. Hospital and Health Services Review 80(5): 223-225
Nicholls, R.M. 1983: IHSA presidential address 1983. Hospital and Health Services Review 79(5): 217-220
Anonymous 1991: IHSM (Institute of Health Services Management) membership. Health Services Management 87(2): 51-52
Jarrold, K.W. 1985: IHSM Presidential Address 1985. Hospital and Health Services Review 81(4): 182-186
Young, B. 1987: IHSM Presidential Address 1987. Hospital and Health Services Review 83(5): 199-203
Fletcher, S. 1991: IHSM Presidential address: The challenge of change. Health Services Management 87(4): 159-162
Jarrold, K. 1985: IHSM presidential address. A plain case for a good cause. Health and Social Service Journal 95(4957): 898-899
Stenager, E.N.; Koch-Henriksen, N.J.; Stenager, E. 1997: Risk factors for suicide in patients with disseminated sclerosis. Ugeskrift for Laeger 159(18): 2690-2693
Amodeo, C.; Giorgi, D.M.; Mion, D.; Nobre, F.; Chaves Júnior, H.; Gomes, M.A.; Atie, C.S.; Pascoal, I.J.; Malachias, M.V.; Passaro, L.C.; Zanela, M.T.; Santelo, J.L.; Wajngarten, M.; Lima, E.G.; Ribeiro, J.M.; Jardim, P.C.; Lima Júnior, E.; Nascimento, R.; Introcaso, L.; Koch, V. 1997: II Brazilian Consensus of Ambulatory Blood Pressure Monitoring. Arquivos Brasileiros de Cardiologia 69(5): 359-367
Cao, Y.; Wang, S.; Li, Y.; Chen, X.; Chen, L.; Wang, D.; Zhu, Z.; Yuan, Y.; Lv, D. 2018: A method for screening active components from Chinese herbs by cell membrane chromatography-offline-high performance liquid chromatography/mass spectrometry and an online statistical tool for data processing. Journal of Chromatography. a 1540: 68-76
Santos Filho, R.D. 2000: II Brazilian consensus about dyslipidemia. Revista da Associacao Medica Brasileira 46(4): 307
Anonymous 2000: II Guidelines of the Brazilian Cardiology Society for acute myocardial infarct treatment. July 22 to 25 of 1999. Teresópolis-RJ. Arquivos Brasileiros de Cardiologia 74 Suppl. 2: 1-46
Anonymous 2002: II Guidelines on Ergometric Tests of the Brazilian Society of Cardiology. Arquivos Brasileiros de Cardiologia 78 Suppl. 2: 1-17
Richardson, C.E.R.; Cunden, L.S.; Butty, V.L.; Nolan, E.M.; Lippard, S.J.; Shoulders, M.D. 2018: A Method for Selective Depletion of Zn(II) Ions from Complex Biological Media and Evaluation of Cellular Consequences of Zn(II) Deficiency. Journal of the American Chemical Society 140(7): 2413-2416
Hepburn, E.; Northway, A.; Bekele, D.; Liu, G.-J.; Currell, M. 2018: A method for separation of heavy metal sources in urban groundwater using multiple lines of evidence. Environmental Pollution 241: 787-799
Hong, G.; Fu, T.-M.; Qiao, M.; Viveros, R.D.; Yang, X.; Zhou, T.; Lee, J.M.; Park, H.-G.; Sanes, J.R.; Lieber, C.M. 2018: A method for single-neuron chronic recording from the retina in awake mice. Science 360(6396): 1447-1451
Schreiber, D.K.; Perea, D.E.; Ryan, J.V.; Evans, J.E.; Vienna, J.D. 2018: A method for site-specific and cryogenic specimen fabrication of liquid/solid interfaces for atom probe tomography. Ultramicroscopy 194: 89-99
Tansukawat, N.D.; See, A.E.; Jiranuntarat, S.; Corbin, J.R.; Schomaker, J.M. 2018: Method for Small-Scale Production of Deuterochloroform. Journal of Organic Chemistry 83(15): 8739-8742
Roquette, J. 1994: II Workshop on Gastroepiploic Artery for Myocardial Revascularization. Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 13(7-8): 616
Han, A. 2018: A Method for Stereological Determination of the Structure Function From Histological Sections of Isotropic Scattering Media. IEEE Transactions on Ultrasonics Ferroelectrics and Frequency Control 65(6): 1007-1016
Anonymous 1999: II nutritional status and life cycle issues. American journal of clinical nutrition 70(3 Suppl): 626S-629S
Tobin, N.H.; Woodward, C.; Zabih, S.; Lee, D.J.; Li, F.; Aldrovandi, G.M. 2018: A Method for Targeted 16S Sequencing of Human Milk Samples. Journal of Visualized Experiments: Jove 2018(133)
Gough, D.B.; Heys, S.D.; Eremin, O. 1996: II--Cancer cachexia: treatments strategies. European Journal of Surgical Oncology: the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 22(3): 286-292
Thurman, R.G. 1998: II. Alcoholic liver injury involves activation of Kupffer cells by endotoxin. American Journal of Physiology 275(4): G605-G611
Miller, S.J. 2000: II. Biopsy techniques for suspected nonmelanoma skin cancers. Dermatologic Surgery: Official Publication for American Society for Dermatologic Surgery 26(1): 91
Rosomoff, H.L.; Fishbain, D.A.; Cutler, R.B.; Steele-Rosomoff, R. 1995: II. do chronic pain patients' perceptions about their preinjury jobs differ as a function of worker compensation and non-worker compensation status?. Clinical Journal of Pain 11(4): 279-286
Tsai, A.M.; van Zanten, J.H.; Betenbaugh, M.J. 1998: II. Electrostatic effect in the aggregation of heat-denatured RNase a and implications for protein additive design. Biotechnology and Bioengineering 59(3): 281-285
Koppang, R.; Berg, E.; Dahm, S.; Real, C.; Fløystrand, F. 1995: A method for testing denture adhesives. Journal of Prosthetic Dentistry 73(5): 486-491
Adler, J.; Raymond, J. 2001: II. Fitness, nutrition, beauty. Fighting back, with sweat. Newsweek 138(11a): 34-41
Underwood, A. 2001: II. Fitness, nutrition, beauty. more veggies, please. Newsweek 138(11a): 42-46
Tyre, P. 2001: II. Fitness, nutrition, beauty. Turning back the clock. Newsweek 138(11a): 48-51
Springen, K. 2001: II. Fitness, nutrition, beauty. what the nurses know. Newsweek 138(11a): 52-53
Rokyta, Z.; Racek, J.; Holecek, V.; Marik, J.J. 1998: II. Free radicals and antioxidants in obstetrics. Ceska Gynekologie 63(4): 340-345
Williams-Hemby, L.; Porrino, L.J. 1997: II. Functional consequences of intragastrically administered ethanol in rats as measured by the 2-[14C]deoxyglucose method: the contribution of dopamine. Alcoholism Clinical and Experimental Research 21(9): 1581-1591
Tapiero, H.; Mathé, G.; Couvreur, P.; Tew, K.D. 2002: II. Glutamine and glutamate. Biomedicine and PharmacoTherapy 56(9): 446-457
Jones, W.; Bellugi, U.; Lai, Z.; Chiles, M.; Reilly, J.; Lincoln, A.; Adolphs, R. 2000: II. Hypersociability in Williams Syndrome. Journal of Cognitive Neuroscience 12(Suppl 1): 30-46
Anonymous 1999: II. Incidence and prevalence of ESRD. American Journal of Kidney Diseases: the Official Journal of the National Kidney Foundation 34(2 Suppl. 1): S40-S50
Jehn, U.; Dengler, R.; Petrides, P.E. 1996: II. Leukemia in the elderly, secondary, recurrent and refractory leukemia, chloroma. Der Internist 37(6): 669-677
Primus, R.J.; Thurkauf, A.; Xu, J.; Yevich, E.; McInerney, S.; Shaw, K.; Tallman, J.F.; Gallagher, D.W. 1997: II. Localization and characterization of dopamine D4 binding sites in rat and human brain by use of the novel, D4 receptor-selective ligand [3H]NGD 94-1. Journal of Pharmacology and Experimental Therapeutics 282(2): 1020-1027
Anonymous 2001: II. NKF-K/DOQI Clinical Practice Guidelines for Peritoneal Dialysis Adequacy: update 2000. American Journal of Kidney Diseases: the Official Journal of the National Kidney Foundation 37(1 Suppl. 1): S65
Pilet, C. 1996: II. on current state of knowledge concerning bovine spongiform encephalopathy (mad cow disease). Comptes Rendus de l'Academie des Sciences. Serie Iii Sciences de la Vie 319(7): 555-557
Andreasen, N.C.; O'Leary, D.S.; Cizadlo, T.; Arndt, S.; Rezai, K.; Watkins, G.L.; Ponto, L.L.; Hichwa, R.D. 1995: II. PET studies of memory: novel versus practiced free recall of word lists. Neuroimage 2(4): 296-305
Isaacs, H. 2002: II. Perinatal brain tumors: a review of 250 cases. Pediatric Neurology 27(5): 333-342
Ruzyłło, E. 1995: II. Physicians and their practice. Wiadomosci Lekarskie 48(1-12): 79-87
Yamakawa, T.; Kotake, Y.; Fujitani, M.; Shintani, H.; Makino, Y.; Ohta, S. 2000: II. Regional distribution in the brain of amines associated with Parkinson's disease. Journal of Neurology 247(1): 73
Alonso Gómez, A.M.; Paré Bardera, C.; Payá Serrano, R.; Placer Peralta, L.J.; San Román Calvar, J.A. 1997: II. Role of Doppler echocardiography in the management of chronic ischemic cardiopathy. Revista Espanola de Cardiologia 50(1): 15-25
Rigotti, N.A. 2000: II. Smoking cessation in the hospital setting-a new opportunity for managed care. Introduction. Tobacco Control 9 Suppl. 1: I54-I55
Manoj; Watson; Hibberd; Fillery-Travis; Robins 1998: II. Steady-State Rheological Investigations. Journal of Colloid and Interface Science 207(2): 294-302
Hazeldine, S.T.; Polin, L.; Kushner, J.; White, K.; Bouregeois, N.M.; Crantz, B.; Palomino, E.; Corbett, T.H.; Horwitz, J.P. 2002: II. Synthesis and biological evaluation of some bioisosteres and congeners of the antitumor agent, 2-(4-[(7-chloro-2-quinoxalinyl)oxy]phenoxy)propionic acid (XK469). Journal of Medicinal Chemistry 45(14): 3130-3137
Bonifacio, A.F. 1979: II. The Institute of Health Sciences: a strategy for health manpower development. World Medical Journal 26(3): 39-43
Shenfield, F.; Pennings, G.; Sureau, C.; Cohen, J.; Tarlatzis, B. 2001: II. the cryopreservation of human embryos. Human Reproduction 16(5): 1049-1050
Friol, J.P.; Chaise, F.; Gaisne, E. 1994: II. the sequelae. Malunion of the distal end of the radius. Annales de Chirurgie 48(1): 82-87
Bewley, S.; Cockburn, J. 2002: II. The unfacts of 'request' caesarean section. Bjog: An International Journal of Obstetrics and Gynaecology 109(6): 597-605
Worthington-Kirsch, R.L.; Andrews, R.T.; Siskin, G.P.; Shlansky-Goldberg, R.; Lipman, J.C.; Goodwin, S.C.; Bonn, J.; Hovsepian, D.M. 2002: II. Uterine fibroid embolization: technical aspects. Techniques in Vascular and Interventional Radiology 5(1): 17-34
König, A.; Walther, M.; Matzer, M.; Heesen, T.; Kirschner, S.; Faller, H. 2000: II. Validity and sensitivity to change of the Musculoskeletal Functional Assessment Questionnaire in primary gonarthrosis and total endoprosthetic joint replacement. Zeitschrift für Orthopadie und ihre Grenzgebiete 138(4): 302-305
Grimaldi, A. 2002: II. Vascular lesions in diabetics. Journal des Maladies Vasculaires 27(5): 269-271; Discussion: 284-286
Kochańska, I.; Nissen, I.; Marszal, J. 2018: A method for testing the wide-sense stationary uncorrelated scattering assumption fulfillment for an underwater acoustic channel. Journal of the Acoustical Society of America 143(2): EL116
Kondo, A.; Sakatani, M.; Tsuchiya, T.; Ogata, H.; Fujiwara, H.; Hara, H.; Yoneda, T.; Sato, K. 1996: II. multidisciplinary analysis of chronic excretors of Mycobacterium tuberculosis bacilli. Kekkaku: 71(1): 25-29
Stubenitsky, B.M.; Booster, M.M.; Brasile, L.; Green, E.M.; Haisch, C.E.; Singh, H.K.; Jacobs, R.W.; Kootstra, G. 2000: II: Ex vivo viability testing of kidneys after postmortem warm ischemia. Asaio Journal 46(1): 62-64
McLellan, S.A.; Walsh, T.S.; McClellan, D.B.L. 2002: II: Should we demand fresh red blood cells for perioperative and critically ill patients?. British Journal of Anaesthesia 89(4): 537-540
Mendenhall, C.L.; Roselle, G.A.; Grossman, C.J.; Gartside, P. 1997: II: the effects of recombinant human insulin-like growth factor-1 on immunological recovery in the malnourished alcoholic rat. Alcoholism Clinical and Experimental Research 21(9): 1682-1689
Santos, R.D. 2001: III Brazilian Guidelines on Dyslipidemias and Guideline of Atherosclerosis Prevention from Atherosclerosis Department of Sociedade Brasileira de Cardiologia. Arquivos Brasileiros de Cardiologia 77 Suppl. 3: 1-48
Balestrieri, G.; Doria, A.; Galeazzi, M.; Meroni, P.L.; Migliorini, P.; Neri, R.; Tavoni, A.; Tincani, A.; Vitali, C.; Bombardieri, S. 1996: III European Conference on Systemic Lupus Erythematosus. Conference summary. Clinical and Experimental Rheumatology 14 Suppl. 16: S3-16
Vankipuram, A.; Traub, S.; Patel, V.L. 2018: A method for the analysis and visualization of clinical workflow in dynamic environments. Journal of Biomedical Informatics 79: 20-31
Kim, U-Jung.; Kannan, K. 2018: Method for the Determination of Iodide in Dried Blood Spots from Newborns by High Performance Liquid Chromatography Tandem Mass Spectrometry. Analytical Chemistry 90(5): 3291-3298
Thulin, L.I.; Sjögren, J.L. 2001: Mechanical versus biological aortic valve implants in the elderly. a comparison of early and mid-term results. Arquivos Brasileiros de Cardiologia 77(5): 395-398
Bullard, W.; Kieft, R.; Sabatini, R. 2017: A method for the efficient and selective identification of 5-hydroxymethyluracil in genomic DNA. Biology Methods and Protocols 2(1)
Dufresne, J.; Florentinus-Mefailoski, A.; Bowden, P.; Marshall, J.G. 2018: A method for the extraction of the endogenous tryptic peptides (peptidome) from human EDTA plasma. Analytical Biochemistry 549: 188-196
Arango, O.; Castillo, M. 2018: A method for the inline measurement of milk gel firmness using an optical sensor. Journal of Dairy Science 101(5): 3910-3917
Angeletti, C. 2018: A Method for the Interpretation of Flow Cytometry Data Using Genetic Algorithms. Journal of Pathology Informatics 9: 16
Anonymous 1999: III biochemical and clinical outcomes. American journal of clinical nutrition 70(3 Suppl): 630S-632S
Krailadsiri, P.; Seghatchian, M.J. 1998: III-7 evaluation of IMAGN 2000: a new system for absolute leucocyte count. Transfusion Science 19(4): 405-407
Soo; Huang; Ming; Kao; Munekata; Chang 1996: III-V diluted magnetic semiconductor: Substitutional doping of Mn in InAs. Physical Review. B Condensed Matter 53(8): 4905-4909
Andreoni 1992: III-V semiconductor microclusters: Structures, stability, and melting. Physical Review. B Condensed Matter 45(8): 4203-4207
Schmidt; Bechstedt; Srivastava 1995: III-V(110) surface dynamics from an ab initio frozen-phonon approach. Physical Review. B Condensed Matter 52(3): 2001-2007
Mikiel-Kostyra, K. 1996: III. Barriers in breastfeeding: hyperbilirubinemia. Pediatria Polska 71(3): 275-278
Matsukawa, A.; Lukacs, N.W.; Hogaboam, C.M.; Chensue, S.W.; Kunkel, S.L. 2001: III. Chemokines and other mediators, 8. Chemokines and their receptors in cell-mediated immune responses in the lung. Microscopy Research and Technique 53(4): 298-306
Ostör, A.G.; Attwood, H.D.; Bettinger, H.F. 1997: III. Dr. Hans Frederick Bettinger. International Journal of Gynecological Pathology: Official Journal of the International Society of Gynecological Pathologists 16(4): 392-395
Mills, D.L.; Alvarez, T.D.; St George, M.; Appelbaum, L.G.; Bellugi, U.; Neville, H. 2000: III. Electrophysiological studies of face processing in Williams syndrome. Journal of Cognitive Neuroscience 12(Suppl 1): 47-64
Jones, B.E.; Czaja, M.J. 1998: III. Intracellular signaling in response to toxic liver injury. American Journal of Physiology 275(5): G874-G878
Barker, D.C. 2000: III. Maternal smoking cessation: a cost effective strategy for managed care. Introduction. Tobacco Control 9 Suppl. 1: I60
Greenberg, S.H.; Springen, K. 2001: III. Mind, moods and stress. Keeping hope alive. Newsweek 138(11a): 60-63
Underwood, A.; Watson, R. 2001: III. Mind, moods and stress. Thanks for the memories. Newsweek 138(11a): 54-58
Blair, G. 2001: III. Mind, moods and stress. the many faces i see. Newsweek 138(11a): 64
Anonymous 2001: III. NKF-K/DOQI Clinical Practice Guidelines for Vascular Access: update 2000. American Journal of Kidney Diseases: the Official Journal of the National Kidney Foundation 37(1 Suppl. 1): S137-S181
Shigematsu, Y.; Korogi, Y.; Hirai, T.; Okuda, T.; Sugahara, T.; Liang, L.; Ge, Y.; Takahashi, M. 1998: III. new developments: 2. Virtual MR endoscopy in the central nervous system. Journal of Magnetic Resonance Imaging: Jmri 8(2): 289-296
Ruzyłło, E. 1995: III. Physicians and their practice. Wiadomosci Lekarskie 48(1-12): 260-265
Simon, D. 2002: III. Practical consequences of recent acquisitions in diabetes. Journal des Maladies Vasculaires 27(5): 272-273; Discussion: 284-286
Pachnis, V.; Durbec, P.; Taraviras, S.; Grigoriou, M.; Natarajan, D. 1998: III. Role of the RET signal transduction pathway in development of the mammalian enteric nervous system. American Journal of Physiology 275(2): G183-G186
Anonymous 1999: III. Treatment modalities for ESRD patients. American Journal of Kidney Diseases: the Official Journal of the National Kidney Foundation 34(2 Suppl. 1): S51-S62
Siskin, G.P.; Bonn, J.; Worthington-Kirsch, R.L.; Smith, S.J.; Shlansky-Goldberg, R.; Machan, L.S.; Andrews, R.T.; Goodwin, S.C.; Hovsepian, D.M. 2002: III. Uterine fibroid embolization: pain management. Techniques in Vascular and Interventional Radiology 5(1): 35-43
Holcomb, B. 1978: III. hospital rate setting board bill is signed. Health Care Week 2(13): 9
Arredondo-García, J.L. 1997: Streptococcus pneumoniae. the appearance of antibiotic resistance. Gaceta Medica de Mexico 133(2): 155-157
Plotkin, B.J.; Davis, J.W.; Strizzi, L.; Lee, P.; Christoffersen-Cebi, J.; Kacmar, J.; Rivero, O.J.; Elsayed, N.; Zanghi, N.; Ito, B.; Sigar, I.M. 2018: A method for the long-term cultivation of mammalian cells in the absence of oxygen: Characterization of cell replication, hypoxia-inducible factor expression and reactive oxygen species production. Tissue and Cell 50: 59-68
Bagavant, H.; Trzeciak, M.; Papinska, J.; Biswas, I.; Dunkleberger, M.L.; Sosnowska, A.; Deshmukh, U.S. 2018: A Method for the Measurement of Salivary Gland Function in Mice. Journal of Visualized Experiments: Jove 2018(131)
Swierkosz, T.A.; Valettas, N.; Herrmann, H.C. 2001: IIb or not IIb: when, how, and which GP IIb/IIIa inhibitor?. Catheterization and Cardiovascular Interventions: Official Journal of the Society for Cardiac Angiography and Interventions 52(4): 433-434
Kereiakes, D.J.; Runyon, J.P.; Broderick, T.M.; Shimshak, T.M. 2000: IIb's are not IIb's. American Journal of Cardiology 85(8a): 23C-31C
Goryainova, O.S.; Ivanova, T.I.; Rutovskaya, M.V.; Tillib, S.V. 2017: A Method for the Parallel and Sequential Generation of Single-Domain Antibodies for the Proteomic Analysis of Human Blood Plasma. Molekuliarnaia Biologiia 51(6): 985-996
Montalescot, G. 1999: IIb/IIIa inhibitors in acute myocardial infarction. Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 10(Suppl 1): S71-S75
Parker, R.I. 2001: IIb/IIIa or not IIb/IIIa, that is adhesion. Critical Care Medicine 29(6): 1286-1287
Redwood, S. 1999: IIb/IIIa or not IIb/IIIa? That is the question. International Journal of Clinical Practice 53(8): 577
Talley, J.D. 1996: IIb/IIIa platelet inhibitors in the management of coronary artery disease. Journal of the Arkansas Medical Society 93(5): 237-239
Hall, D.A.; Giraldo, J.ús. 2018: A method for the quantification of biased signalling at constitutively active receptors. British Journal of Pharmacology 175(11): 2046-2062
Anonymous 2000: IJNP Calendar. international journal of neuropsychopharmacology 3(4): 357
Wang, J.; Morishima, S.; Okada, Y. 2003: IK channels are involved in the regulatory volume decrease in human epithelial cells. American Journal of Physiology. Cell Physiology 284(1): C77-C84
Lohberger, B.; Groschner, K.; Tritthart, H.; Schreibmayer, W. 2000: IK.ACh activation by arachidonic acid occurs via a G-protein-independent pathway mediated by the GIRK1 subunit. Pflugers Archiv: European Journal of Physiology 441(2-3): 251-256
Kleber, A.G. 1994: IK1 blockade as an antiarrhythmic mechanism. Cardiovascular Research 28(5): 720
Rees, S.A.; Curtis, M.J. 1994: IK1 blockade is a potentially useful antiarrhythmic mechanism. Cardiovascular Research 28(3): 421
Opthof, T. 1994: IK1 blockade is unlikely to be a useful antiarrhythmic mechanism. Cardiovascular Research 28(3): 420
Malý, J. 2002: IKEM (The Institute for Clinical and Experimental Medicine)--undergraduate and postgraduate education. Casopis Lekaru Ceskych 141(10): 324-325
DiDonato, J.A. 2001: IKK alpha on center stage. Science's Stke: Signal Transduction Knowledge Environment 97: Pe1
Haller, D.; Russo, M.P.; Sartor, R.Balfour.; Jobin, C. 2002: IKK beta and phosphatidylinositol 3-kinase/Akt participate in non-pathogenic Gram-negative enteric bacteria-induced RelA phosphorylation and NF-kappa B activation in both primary and intestinal epithelial cell lines. Journal of Biological Chemistry 277(41): 38168-38178
Regula, K.M.; Ens, K.; Kirshenbaum, L.A. 2002: IKK beta is required for Bcl-2-mediated NF-kappa B activation in ventricular myocytes. Journal of Biological Chemistry 277(41): 38676-38682
Li, X.; Massa, P.E.; Hanidu, A.; Peet, G.W.; Aro, P.; Savitt, A.; Mische, S.; Li, J.; Marcu, K.B. 2002: IKKalpha, IKKbeta, and NEMO/IKKgamma are each required for the NF-kappa B-mediated inflammatory response program. Journal of Biological Chemistry 277(47): 45129-45140
Fisher, C. 2000: IKKalpha-/- mice share phenotype with pupoid fetus (pf/pf) and repeated epilation (Er/Er) mutant mice. Trends in Genetics: Tig 16(11): 482-484
Yamamoto, Y.; Kim, D.W.; Kwak, Y.T.; Prajapati, S.; Verma, U.; Gaynor, R.B. 2001: IKKgamma /NEMO facilitates the recruitment of the IkappaB proteins into the IkappaB kinase complex. Journal of Biological Chemistry 276(39): 36327-36336
Wolf, J.S.; Chen, Z.; Dong, G.; Sunwoo, J.B.; Bancroft, C.C.; Capo, D.E.; Yeh, N.T.; Mukaida, N.; Van Waes, C. 2001: IL (interleukin)-1alpha promotes nuclear factor-kappaB and AP-1-induced IL-8 expression, cell survival, and proliferation in head and neck squamous cell carcinomas. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 7(6): 1812-1820
Kisner, H.J. 1991: IL Monarch System--Instrumentation Laboratories. Clinical Laboratory Management Review: Official Publication of the Clinical Laboratory Management Association 5(2): 117-119
Li, J.; Farthing, P.M.; Ireland, G.W.; Thornhill, M.H. 1996: IL-1 alpha and IL-6 production by oral and skin keratinocytes: similarities and differences in response to cytokine treatment in vitro. Journal of Oral Pathology and Medicine: Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 25(4): 157-162
Shibuya, K.; Robinson, D.; Zonin, F.; Hartley, S.B.; Macatonia, S.E.; Somoza, C.; Hunter, C.A.; Murphy, K.M.; O'Garra, A. 1998: IL-1 alpha and TNF-alpha are required for IL-12-induced development of Th1 cells producing high levels of IFN-gamma in BALB/c but not C57BL/6 mice. Journal of Immunology 160(4): 1708-1716
Fouad, A.F. 1997: IL-1 alpha and TNF-alpha expression in early periapical lesions of normal and immunodeficient mice. Journal of Dental Research 76(9): 1548-1554
Joosten, L.A.; Helsen, M.M.; Saxne, T.; van De Loo, F.A.; Heinegard, D.; van Den Berg, W.B. 1999: IL-1 alpha beta blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-alpha blockade only ameliorates joint inflammation. Journal of Immunology 163(9): 5049-5055
Kawaguchi, Y. 1994: IL-1 alpha gene expression and protein production by fibroblasts from patients with systemic sclerosis. Clinical and Experimental Immunology 97(3): 445-450
Speiser, P.; Zeillinger, R.; Wiltschke, C.; Sedlák, J.; Chorváth, B. 1993: IL-1 alpha induced, TNF alpha mediated HLA class Ii (DR) antigen up-regulation in a human ductal breast carcinoma cell line ZR-75-1. Neoplasma 40(3): 137-140
Yamamoto, S.; Kamada, M.; Maegawa, M.; Takikawa, M.; Nakaya, Y.; Niwa, M.; Aono, T. 1997: IL-1 alpha induces inducible nitric oxide synthase in uterine smooth muscle. Biochemical and Biophysical Research Communications 238(1): 12-16
Harmon, C.S.; Nevins, T.D. 1993: IL-1 alpha inhibits human hair follicle growth and hair fiber production in whole-organ cultures. Lymphokine and Cytokine Research 12(4): 197-203
Bonifati, C.; Carducci, M.; Mussi, A.; D'auria, L.; Ameglio, F. 1997: IL-1 alpha, IL-1 beta and psoriasis: conflicting results in the literature. Opposite behaviour of the two cytokines in lesional or non-lesional extracts of whole skin. Journal of Biological Regulators and Homeostatic Agents 11(4): 133-136
Nakae, S.; Naruse-Nakajima, C.; Sudo, K.; Horai, R.; Asano, M.; Iwakura, Y. 2001: IL-1 alpha, but not IL-1 beta, is required for contact-allergen-specific T cell activation during the sensitization phase in contact hypersensitivity. International Immunology 13(12): 1471-1478
Knerer, B.; Hulla, W.; Martinek, H.; Formanek, M.; Temmel, A.; Kornfehl, J. 1996: IL-1 and TNF-alpha but no IL-2 expression is found in squamous cell carcinomas of the head and neck by RT-PCR. Acta Oto-Laryngologica 116(1): 132-136
Yamagishi, S.; Ohnishi, M.; Pawankar, R. 2000: IL-1 and TNF-alpha-mediated regulation of IL-6, IL-8, and GM-CSF release from cultured nasal epithelial cells. Nihon Jibiinkoka Gakkai Kaiho 103(7): 829-835
Fagarasan, M.O.; Aisen, P.S. 1996: IL-1 and anti-inflammatory drugs modulate a beta cytotoxicity in PC12 cells. Brain Research 723(1-2): 231-234
Fauteux, L.J.; Osmond, D.G. 1996: IL-1 as systemic modifier of B lymphopoiesis. Recombinant IL-1 alpha binds to stromal cells and sinusoid endothelium in bone marrow and precursor B cell dynamics. Journal of Immunology 156(7): 2376-2383
Siegmund, B.; Lehr, H.A.; Fantuzzi, G.; Dinarello, C.A. 2001: IL-1 beta -converting enzyme (caspase-1) in intestinal inflammation. Proceedings of the National Academy of Sciences of the United States of America 98(23): 13249-13254
Nylander-Lundqvist, E.; Bäck, O.; Egelrud, T. 1996: IL-1 beta activation in human epidermis. Journal of Immunology 157(4): 1699-1704
Kelsen, S.G.; Anakwe, O.; Aksoy, M.O.; Reddy, P.J.; Dhanasekaran, N. 1997: IL-1 beta alters beta-adrenergic receptor adenylyl cyclase system function in human airway epithelial cells. American Journal of Physiology 273(3 Part 1): L694-L700
Li, Y.Y.; McTiernan, C.F.; Feldman, A.M. 1998: IL-1 beta alters the expression of the receptor tyrosine kinase gene r-EphA3 in neonatal rat cardiomyocytes. American Journal of Physiology 274(1): H331-H341
Angel, J.; Audubert, F.; Bismuth, G.; Fournier, C. 1994: IL-1 beta amplifies bradykinin-induced prostaglandin E2 production via a phospholipase D-linked mechanism. Journal of Immunology 152(10): 5032-5040
Wei, L.; Debets, R.; Hegmans, J.J.; Benner, R.; Prens, E.P. 1999: IL-1 beta and IFN-gamma induce the regenerative epidermal phenotype of psoriasis in the transwell skin organ culture system. IFN-gamma up-regulates the expression of keratin 17 and keratinocyte transglutaminase via endogenous IL-1 production. Journal of Pathology 187(3): 358-364
Bessler, H.; Sirota, L.; Notti, I.; Dulitzky, F.; Djaldetti, M. 1993: IL-1 beta and IL-3-like activity in preterm infants. Clinical and Experimental Immunology 91(2): 320-324
Tanda, N.; Ohyama, H.; Yamakawa, M.; Ericsson, M.; Tsuji, T.; McBride, J.; Elovic, A.; Wong, D.T.; Login, G.R. 1998: IL-1 beta and IL-6 in mouse parotid acinar cells: characterization of synthesis, storage, and release. American Journal of Physiology 274(1): G147-G156
Villiger, P.M.; Kusari, A.B.; ten Dijke, P.; Lotz, M. 1993: IL-1 beta and IL-6 selectively induce transforming growth factor-beta isoforms in human articular chondrocytes. Journal of Immunology 151(6): 3337-3344
Machein, U.; Lieb, K.; Hüll, M.; Fiebich, B.L. 1995: IL-1 beta and TNF alpha, but not IL-6, induce alpha 1-antichymotrypsin expression in the human astrocytoma cell line U373 MG. Neuroreport 6(17): 2283-2286
Song, H.; Saito, K.; Fujigaki, S.; Noma, A.; Ishiguro, H.; Nagatsu, T.; Seishima, M. 1998: IL-1 beta and TNF-alpha suppress apolipoprotein (apo) e secretion and apo A-i expression in HepG2 cells. Cytokine 10(4): 275-280
Tian, Z.; Shen, X.; Feng, H.; Gao, B. 2000: IL-1 beta attenuates IFN-alpha beta-induced antiviral activity and STAT1 activation in the liver: involvement of proteasome-dependent pathway. Journal of Immunology 165(7): 3959-3965
Smith, D.J.; McGuire, M.J.; Tocci, M.J.; Thiele, D.L. 1997: IL-1 beta convertase (ICE) does not play a requisite role in apoptosis induced in T lymphoblasts by Fas-dependent or Fas-independent CTL effector mechanisms. Journal of Immunology 158(1): 163-170
Fiorucci, S.; Santucci, L.; Cirino, G.; Mencarelli, A.; Familiari, L.; Soldato, P.D.; Morelli, A. 2000: IL-1 beta converting enzyme is a target for nitric oxide-releasing aspirin: new insights in the antiinflammatory mechanism of nitric oxide-releasing nonsteroidal antiinflammatory drugs. Journal of Immunology 165(9): 5245-5254
Yang, F.; Jansen, L.; Friedrichs, W.E.; Buchanan, J.M.; Bowman, B.H. 1993: IL-1 beta decreases expression of amyloid precursor protein gene in human glioma cells. Biochemical and Biophysical Research Communications 191(3): 1014-1019
Ogilvie, A.C.; Hack, C.E.; Wagstaff, J.; van Mierlo, G.J.; Erenberg, A.J.; Thomsen, L.L.; Hoekman, K.; Rankin, E.M. 1996: IL-1 beta does not cause neutrophil degranulation but does lead to IL-6, IL-8, and nitrite/nitrate release when used in patients with cancer. Journal of Immunology 156(1): 389-394
Luft, T.; Jefford, M.; Luetjens, P.; Hochrein, H.; Masterman, K.-A.; Maliszewski, C.; Shortman, K.; Cebon, J.; Maraskovsky, E. 2002: IL-1 beta enhances CD40 ligand-mediated cytokine secretion by human dendritic cells (DC): a mechanism for T cell-independent DC activation. Journal of Immunology 168(2): 713-722
Horie, H.; Sakai, I.; Akahori, Y.; Kadoya, T. 1997: IL-1 beta enhances neurite regeneration from transected-nerve terminals of adult rat DRG. Neuroreport 8(8): 1955-1959
Mao, C.; Singh, A.K. 1996: IL-1 beta gene expression in B cells derived from the murine MRL/lpr model of lupus. Autoimmunity 24(2): 71-79
Patten, M.; Wang, W.; Aminololama-Shakeri, S.; Burson, M.; Long, C.S. 2000: IL-1 beta increases abundance and activity of the negative transcriptional regulator yin yang-1 (YY1) in neonatal rat cardiac myocytes. Journal of Molecular and Cellular Cardiology 32(7): 1341-1352
Bradford, P.G.; Maglich, J.M.; Kirkwood, K.L. 2000: IL-1 beta increases type 1 inositol trisphosphate receptor expression and IL-6 secretory capacity in osteoblastic cell cultures. Molecular Cell Biology Research Communications: Mcbrc 3(2): 73-75
Tsuzaki, M.; Guyton, G.; Garrett, W.; Archambault, J.M.; Herzog, W.; Almekinders, L.; Bynum, D.; Yang, X.; Banes, A.J. 2003: IL-1 beta induces COX2, MMP-1, -3 and -13, ADAMTS-4, IL-1 beta and IL-6 in human tendon cells. Journal of Orthopaedic Research: Official Publication of the Orthopaedic Research Society 21(2): 256-264
Wesa, A.K.; Galy, A. 2001: IL-1 beta induces dendritic cells to produce IL-12. International Immunology 13(8): 1053-1061
Homaidan, F.R.; Zhao, L.; Burakoff, R. 1997: IL-1 beta induces synthesis of phospholipase A2-activating protein in rabbit distal colon. American Journal of Physiology 272(6 Part 1): G1338-G1346
Bird, J.L.; Wells, T.; Platt, D.; Bayliss, M.T. 1997: IL-1 beta induces the degradation of equine articular cartilage by a mechanism that is not mediated by nitric oxide. Biochemical and Biophysical Research Communications 238(1): 81-85
Odoux, C.; Crestani, B.; Lebrun, G.; Rolland, C.; Aubin, P.; Fournier, T.; Fiet, J.; Aubier, M. 1997: IL-1 beta inhibits ET-1 production by ATIi cells in vitro: evidence for involvement of cyclooxygenase 2 pathway. American Journal of Physiology 273(1 Part 1): L193-L200
Rohn, W.; Tang, L.P.; Dong, Y.; Benveniste, E.N. 1999: IL-1 beta inhibits IFN-gamma-induced class Ii MHC expression by suppressing transcription of the class Ii transactivator gene. Journal of Immunology 162(2): 886-896
Delikat, S.; Harris, R.J.; Galvani, D.W. 1993: IL-1 beta inhibits adipocyte formation in human long-term bone marrow culture. Experimental Hematology 21(1): 31-37
Clarke, D.J.; Branton, R.L. 2002: IL-1 beta is released from the host brain following transplantation but does not compromise embryonic dopaminergic neuron survival. Brain Research 952(1): 78-85
Yin, L.; Li, L.; Pan, Y.; Tan, Y.; He, A. 2001: IL-1 beta mRNA and TNF-alpha mRNA expression in gingival tissues of patients with adult periodontitis. Hua Xi Kou Qiang Yi Xue Za Zhi 19(5): 318-321
Tokoro, Y.; Yamamoto, T.; Hara, K. 1996: IL-1 beta mRNA as the predominant inflammatory cytokine transcript: correlation with inflammatory cell infiltration into human gingiva. Journal of Oral Pathology and Medicine: Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 25(5): 225-231
Faggioni, R.; Fantuzzi, G.; Fuller, J.; Dinarello, C.A.; Feingold, K.R.; Grunfeld, C. 1998: IL-1 beta mediates leptin induction during inflammation. American Journal of Physiology 274(1): R204-R208
Linner, K.M.; Nicol, S.E.; Sharp, B.M. 1993: IL-1 beta modulates the concanavalin-A-induced expression of proenkephalin a mRNA in murine thymocytes. Journal of Pharmacology and Experimental Therapeutics 267(3): 1566-1572
Obreja, O.; Rathee, P.K.; Lips, K.S.; Distler, C.; Kress, M. 2002: IL-1 beta potentiates heat-activated currents in rat sensory neurons: involvement of IL-1RI, tyrosine kinase, and protein kinase C. Faseb Journal: Official Publication of the Federation of American Societies for Experimental Biology 16(12): 1497-1503
Raber, J.; Pich, E.M.; Koob, G.F.; Bloom, F.E. 1994: IL-1 beta potentiates the acetylcholine-induced release of vasopressin from the hypothalamus in vitro, but not from the amygdala. Neuroendocrinology 59(3): 208-217
Brandolini, L.; Bertini, R.; Bizzarri, C.; Sergi, R.; Caselli, G.; Zhou, D.; Locati, M.; Sozzani, S. 1996: IL-1 beta primes IL-8-activated human neutrophils for elastase release, phospholipase D activity, and calcium flux. Journal of Leukocyte Biology 59(3): 427-434
Brooks, C.J.; King, W.J.; Radford, D.J.; Adu, D.; McGrath, M.; Savage, C.O. 1996: IL-1 beta production by human polymorphonuclear leucocytes stimulated by anti-neutrophil cytoplasmic autoantibodies: relevance to systemic vasculitis. Clinical and Experimental Immunology 106(2): 273-279
Kühn, K.; Hashimoto, S.; Lotz, M. 2000: IL-1 beta protects human chondrocytes from CD95-induced apoptosis. Journal of Immunology 164(4): 2233-2239
Brand, C.U.; Hunziker, T.; Yawalkar, N.; Braathen, L.R. 1996: IL-1 beta protein in human skin lymph does not discriminate allergic from irritant contact dermatitis. Contact Dermatitis 35(3): 152-156
Hirata, F.; Lee, J.Y.; Sakamoto, T.; Nomura, A.; Uchida, Y.; Hirata, A.; Hasegawa, S. 1994: IL-1 beta regulates the expression of the Gi2 alpha gene via lipid mediators in guinea pig tracheal muscle. Biochemical and Biophysical Research Communications 203(3): 1889-1896
Hastie, A.T.; Everts, K.B.; Cho, S.K.; Zangrilli, J.; Shaver, J.R.; Pollice, M.B.; Fish, J.E.; Peters, S.P. 1996: IL-1 beta release from cultured bronchial epithelial cells and bronchoalveolar lavage cells from allergic and normal humans following segmental challenge with ragweed. Cytokine 8(9): 730-738
Srivastava, S.K.; Tetsuka, T.; Daphna-Iken, D.; Morrison, A.R. 1994: IL-1 beta stabilizes COX II mRNA in renal mesangial cells: role of 3'-untranslated region. American Journal of Physiology 267(3 Pt 2): F504-F508
Boota, A.; Zar, H.; Kim, Y.M.; Johnson, B.; Pitt, B.; Davies, P. 1996: IL-1 beta stimulates superoxide and delayed peroxynitrite production by pulmonary vascular smooth muscle cells. American Journal of Physiology 271(6 Part 1): L932-L938
Vassiliadis, S.; Soteriadou, K.P.; Papadopoulos, G.K. 1997: IL-1 beta transduces different signals than IL-1 alpha leading to class Ii antigen expression on beta-insulinoma RIN-5AH cells through specific receptors. Journal of Receptor and Signal Transduction Research 17(1-3): 211-225
Wong, M.L.; Bongiorno, P.B.; al-Shekhlee, A.; Esposito, A.; Khatri, P.; Licinio, J. 1996: IL-1 beta, IL-1 receptor type i and iNOS gene expression in rat brain vasculature and perivascular areas. Neuroreport 7(15-17): 2445-2448
Bessler, H.; Djaldetti, R.; Salman, H.; Bergman, M.; Djaldetti, M. 1999: IL-1 beta, IL-2, IL-6 and TNF-alpha production by peripheral blood mononuclear cells from patients with Parkinson's disease. Biomedicine and PharmacoTherapy 53(3): 141-145
Keenan, J.A.; Chen, T.T.; Chadwell, N.L.; Torry, D.S.; Caudle, M.R. 1995: IL-1 beta, TNF-alpha, and IL-2 in peritoneal fluid and macrophage-conditioned media of women with endometriosis. American Journal of Reproductive Immunology 34(6): 381-385
Yung, S.; Coles, G.A.; Davies, M. 1996: IL-1 beta, a major stimulator of hyaluronan synthesis in vitro of human peritoneal mesothelial cells: relevance to peritonitis in CAPD. Kidney international 50(4): 1337-1343
Kehlen, A.; Lauterbach, R.; Santos, A.N.; Thiele, K.; Kabisch, U.; Weber, E.; Riemann, D.; Langner, J. 2001: IL-1 beta- and IL-4-induced down-regulation of autotaxin mRNA and PC-1 in fibroblast-like synoviocytes of patients with rheumatoid arthritis (RA). Clinical and Experimental Immunology 123(1): 147-154
Wewers, M.D.; Dare, H.A.; Winnard, A.V.; Parker, J.M.; Miller, D.K. 1997: IL-1 beta-converting enzyme (ICE) is present and functional in human alveolar macrophages: macrophage IL-1 beta release limitation is ICE independent. Journal of Immunology 159(12): 5964-5972
Ayala, J.M.; Yamin, T.T.; Egger, L.A.; Chin, J.; Kostura, M.J.; Miller, D.K. 1994: IL-1 beta-converting enzyme is present in monocytic cells as an inactive 45-kDa precursor. Journal of Immunology 153(6): 2592-2599
Xie, J.F.; Stroumza, J.; Graves, D.T. 1994: IL-1 down-regulates platelet-derived growth factor-alpha receptor gene expression at the transcriptional level in human osteoblastic cells. Journal of Immunology 153(1): 378-383
Feloutzis, A.; Lang, N.P.; Tonetti, M.S.; Bürgin, W.; Brägger, U.; Buser, D.; Duff, G.W.; Kornman, K.S. 2003: IL-1 gene polymorphism and smoking as risk factors for peri-implant bone loss in a well-maintained population. Clinical Oral Implants Research 14(1): 10-17
Reinhardt, R.A.; Masada, M.P.; Johnson, G.K.; DuBois, L.M.; Seymour, G.J.; Allison, A.C. 1993: IL-1 in gingival crevicular fluid following closed root planing and papillary flap debridement. Journal of Clinical Periodontology 20(7): 514-519
Camacho, M.; Godessart, N.; Vila, L. 1997: IL-1 increases the ability of human endothelial cells to transform linoleic acid into monohydroxy-isomers and their incorporation into cell lipids. Advances in Experimental Medicine and Biology 400b: 647-654
Gabay, C. 2000: IL-1 inhibitors: novel agents in the treatment of rheumatoid arthritis. Expert Opinion on Investigational Drugs 9(1): 113-127
Aime, C.; Bristol, L.; Cohen-Kaminsky, S.; Berrih-Aknin, S.; Durum, S.; Takács, L. 1993: IL-1 mRNA expression detected by in situ hybridization and polymerase chain reaction in human thymus and thymoma. Correlation with late T-cell maturation in normal versus neoplastic thymus. Thymus 22(1): 45-54
Thom, A.K.; Fraker, D.L.; Norton, J.A. 1993: IL-1 receptor antagonist (IL-1ra) augments IL-2-induced pulmonary vascular leak. Journal of Surgical Research 54(4): 336-341
Thompson, R.C. 1993: IL-1 receptor antagonist in arthritis and arthritis models. Clinical and Experimental Rheumatology 11(Suppl 8): S169
Swantek, J.L.; Tsen, M.F.; Cobb, M.H.; Thomas, J.A. 2000: IL-1 receptor-associated kinase modulates host responsiveness to endotoxin. Journal of Immunology 164(8): 4301-4306
Weng, J.; Mohan, R.R.; Li, Q.; Wilson, S.E. 1997: IL-1 upregulates keratinocyte growth factor and hepatocyte growth factor mRNA and protein production by cultured stromal fibroblast cells: interleukin-1 beta expression in the cornea. Cornea 16(4): 465-471
O'Neill, L. 2001: IL-1 versus TNF in arthritis?. Trends in Immunology 22(7): 353-354
Allam, A.F.; Osman, M.M.; el-Sayed, M.H.; Demian, S.R. 2000: IL-1, IL-4 production and IgE levels in acute and chronic fasciolosis before and after triclabendazole treatment. Journal of the Egyptian Society of Parasitology 30(3): 781-790
Li, X.; Commane, M.; Jiang, Z.; Stark, G.R. 2001: IL-1-induced NFkappa B and c-Jun N-terminal kinase (JNK) activation diverge at IL-1 receptor-associated kinase (IRAK). Proceedings of the National Academy of Sciences of the United States of America 98(8): 4461-4465
Chao, C.C.; Lokensgard, J.R.; Sheng, W.S.; Hu, S.; Peterson, P.K. 1997: IL-1-induced iNOS expression in human astrocytes via NF-kappa B. Neuroreport 8(14): 3163-3166
Lacey, D.L.; Grosso, L.E.; Moser, S.A.; Erdmann, J.; Tan, H.L.; Pacifici, R.; Villareal, D.T. 1993: IL-1-induced murine osteoblast IL-6 production is mediated by the type 1 IL-1 receptor and is increased by 1,25 dihydroxyvitamin D3. Journal of Clinical Investigation 91(4): 1731-1742
Origuchi, T.; Migita, K.; Nakashima, T.; Tominaga, M.; Nakamura, H.; Nakashima, M.; Aoyagi, T.; Kawakami, A.; Kawabe, Y.; Eguchi, K. 2000: IL-1-mediated expression of membrane type matrix-metalloproteinase in rheumatoid osteoblasts. Clinical and Experimental Rheumatology 18(3): 333-339
Press, R.; Deretzi, G.; Zou, L.P.; Zhu, J.; Fredman, P.; Lycke, J.; Link, H. 2001: IL-10 and IFN-gamma in Guillain-Barré syndrome. Network Members of the Swedish Epidemiological Study Group. Journal of Neuroimmunology 112(1-2): 129-138
Pousset, F.; Cremona, S.; Dantzer, R.; Kelley, K.W.; Parnet, P. 2001: IL-10 and IL-4 regulate type-i and type-Ii IL-1 receptors expression on IL-1 beta-activated mouse primary astrocytes. Journal of Neurochemistry 79(4): 726-736
Carrington, L.; McLeod, D.; Boulton, M. 2000: IL-10 and antibodies to TGF-beta2 and PDGF inhibit RPE-mediated retinal contraction. Investigative Ophthalmology and Visual Science 41(5): 1210-1216
Stearns, M.E.; Wang, M.; Stearns, M. 1995: IL-10 blocks collagen IV invasion by "invasion stimulating factor" activated PC-3 ML cells: upregulation of TIMP-1 expression. Oncology Research 7(3-4): 157-163
Bosshardt, S.C.; Freeman, G.L.; Secor, W.E.; Colley, D.G. 1997: IL-10 deficit correlates with chronic, hypersplenomegaly syndrome in male CBA/J mice infected with Schistosoma mansoni. Parasite Immunology 19(8): 347-353
Gollnick, S.O.; Musser, D.A.; Oseroff, A.R.; Vaughan, L.; Owczarczak, B.; Henderson, B.W. 2001: IL-10 does not play a role in cutaneous Photofrin photodynamic therapy-induced suppression of the contact hypersensitivity response. Photochemistry and Photobiology 74(6): 811-816
Park, D.R.; Skerrett, S.J. 1996: IL-10 enhances the growth of Legionella pneumophila in human mononuclear phagocytes and reverses the protective effect of IFN-gamma: differential responses of blood monocytes and alveolar macrophages. Journal of Immunology 157(6): 2528-2538
El-Malky, B.S.; Soliman, M.; Mageid, A.A.; el-Nemr, H.E.; el-Nashar, E.M.; Hawas, S. 2001: IL-10 gene expression as a marker for detection of protective immunity levels with irradiated cercarial vaccine against experimental Schistosoma mansoni infection. Journal of the Egyptian Society of Parasitology 31(3): 745
Book, A.A.; Fielding, K.E.; Kundu, N.; Wilson, M.A.; Fulton, A.M.; Laterra, J. 1998: IL-10 gene transfer to intracranial 9L glioma: tumor inhibition and cooperation with IL-2. Journal of Neuroimmunology 92(1-2): 50-59
Otsuki, T.; Yata, K.; Sakaguchi, H.; Uno, M.; Fujii, T.; Wada, H.; Sugihara, T.; Ueki, A. 2002: IL-10 in myeloma cells. Leukemia and Lymphoma 43(5): 969-974
Blackstone, M.O. 2001: IL-10 in post ERCP pancreatitis. Gastroenterology 121(1): 233; Author Reply 233-4
Dieu-Nosjean, M.C.; Massacrier, C.; Vanbervliet, B.; Fridman, W.H.; Caux, C. 2001: IL-10 induces CCR6 expression during Langerhans cell development while IL-4 and IFN-gamma suppress it. Journal of Immunology 167(10): 5594-5602
Romano, M.F.; Lamberti, A.; Petrella, A.; Bisogni, R.; Tassone, P.F.; Formisano, S.; Venuta, S.; Turco, M.C. 1996: IL-10 inhibits nuclear factor-kappa B/Rel nuclear activity in CD3-stimulated human peripheral T lymphocytes. Journal of Immunology 156(6): 2119-2123
Buelens, C.; Willems, F.; Piérard, G.; Delvaux, A.; Velu, T.; Goldman, M. 1995: IL-10 inhibits the primary allogeneic T cell response to human peripheral blood dendritic cells. Advances in Experimental Medicine and Biology 378: 363-365
Allen, E.M.; Luzina, I.G.; Huang, S.K. 2000: IL-10 kinetics in thyroiditis-prone BB/Wor rats. Autoimmunity 32(4): 229-240
Viana da Costa, A.; Huerre, M.; Delacre, M.; Auriault, C.; Correia Costa, J.é M.; Verwaerde, C. 2002: IL-10 leads to a higher parasite persistence in a resistant mouse model of Leishmania major infection. Parasitology International 51(4): 367-379
Allavena, P.; Piemonti, L.; Longoni, D.; Bernasconi, S.; Stoppacciaro, A.; Ruco, L.; Mantovani, A. 1997: IL-10 prevents the generation of dendritic cells from CD14+ blood monocytes, promotes the differentiation to mature macrophages and stimulates endocytosis of FITC-dextran. Advances in Experimental Medicine and Biology 417: 323-327
Egle, A.; Marschitz, I.; Posch, B.; Herold, M.; Greil, R. 1996: IL-10 serum levels in B-cell chronic lymphocytic leukaemia. British Journal of Haematology 94(1): 211-212
Stelmach, I.; Jerzyńska, J.; Bobrowska, M.; Brzozowska, A.; Majak, P.ł; Kuna, P. 2002: IL-10 serum levels in children with moderate asthma. Pneumonologia i Alergologia Polska 70(1-2): 25-33
Morinobu, A.; Kumagai, S.; Yanagida, H.; Ota, H.; Ishida, H.; Matsui, M.; Yodoi, J.; Nakao, K. 1996: IL-10 suppresses cell surface CD23/Fc epsilon RIi expression, not by enhancing soluble CD23 release, but by reducing CD23 mRNA expression in human monocytes. Journal of Clinical Immunology 16(6): 326-333
Rouleau, M.; Cottrez, F.; Bigler, M.; Antonenko, S.; Carballido, J.M.; Zlotnik, A.; Roncarolo, M.G.; Groux, H. 1999: IL-10 transgenic mice present a defect in T cell development reminiscent of SCID patients. Journal of Immunology 163(3): 1420-1427
Osman, M.M.; Abo-El-Nazar, S.Y. 1999: IL-10, IFN-gamma and TNF-alpha in acute and chronic human fascioliasis. Journal of the Egyptian Society of Parasitology 29(1): 13-20
Lehmann, J.; Seegert, D.; Strehlow, I.; Schindler, C.; Lohmann-Matthes, M.L.; Decker, T. 1994: IL-10-induced factors belonging to the p91 family of proteins bind to IFN-gamma-responsive promoter elements. Journal of Immunology 153(1): 165-172
Clarke, C.J.; Hales, A.; Hunt, A.; Foxwell, B.M. 1998: IL-10-mediated suppression of TNF-alpha production is independent of its ability to inhibit NF kappa B activity. European Journal of Immunology 28(5): 1719-1726
Wang, M.; Hu, Y.; Shima, I.; Stearns, M.E. 2002: IL-10/IL-10 receptor signaling regulates TIMP-1 expression in primary human prostate tumor lines. Cancer Biology and Therapy 1(5): 556-563
Terkeltaub, R.A. 1999: IL-10: An "immunologic scalpel" for atherosclerosis?. Arteriosclerosis Thrombosis and Vascular Biology 19(12): 2823-2825
Borish, L. 1998: IL-10: evolving concepts. Journal of Allergy and Clinical Immunology 101(3): 293-297
Dams-Kozlowska, H.; Izycki, D.; Mackiewicz, A. 2001: IL-11 is a potent anti-melanoma factor. Advances in Experimental Medicine and Biology 495: 373-377
Nadler; Stanford; Zhang; Upperman; Ford 2000: IL-11 is upregulated in human NEC. Current Surgery 57(6): 639
Trepicchio, W.L.; Wang, L.; Bozza, M.; Dorner, A.J. 1997: IL-11 regulates macrophage effector function through the inhibition of nuclear factor-kappaB. Journal of Immunology 159(11): 5661-5670
Grohmann, U.; Bianchi, R.; Belladonna, M.L.; Vacca, C.; Silla, S.; Ayroldi, E.; Fioretti, M.C.; Puccetti, P. 1999: IL-12 acts selectively on CD8 alpha- dendritic cells to enhance presentation of a tumor peptide in vivo. Journal of Immunology 163(6): 3100-3105
Horvath-Arcidiacono, J.A.; Mostowski, H.S.; Bloom, E.T. 1996: IL-12 administered in vivo to young and aged mice. Discrepancy between the effects on tumor growth in vivo and cytotoxic T lymphocyte generation ex vivo: dependence on IFN-gamma. International Immunology 8(5): 661-673
Trembleau, S.; Gregori, S.; Penna, G.; Gorny, I.; Adorini, L. 2001: IL-12 administration reveals diabetogenic T cells in genetically resistant I-Ealpha-transgenic nonobese diabetic mice: resistance to autoimmune diabetes is associated with binding of Ealpha-derived peptides to the I-A(g7) molecule. Journal of Immunology 167(7): 4104-4114
Ponti, C.; Falconi, M.; Billi, A.M.; Faenza, I.; Castorina, S.; Caimi, L.; Cacchioli, A.; Cocco, L.; Vitale, M. 2002: IL-12 and IL-15 induce activation of nuclear PLCbeta in human natural killer cells. International Journal of Oncology 20(1): 149-153
Barbulescu, K.; Becker, C.; Schlaak, J.F.; Schmitt, E.; Meyer zum Büschenfelde, K.H.; Neurath, M.F. 1998: IL-12 and IL-18 differentially regulate the transcriptional activity of the human IFN-gamma promoter in primary CD4+ T lymphocytes. Journal of Immunology 160(8): 3642-3647
Verma, V.; Sharma, V.; Shrivastava, S.K.; Nadkarni, J.J. 2000: IL-12 and IL-2 potentiate the in vitro tumor-specific activity of peripheral blood cells from cervical cancer patients. Journal of Experimental and Clinical Cancer Research: Cr 19(3): 367-374
Komastu, T.; Ireland, D.D.; Reiss, C.S. 1998: IL-12 and viral infections. Cytokine and Growth Factor Reviews 9(3-4): 277-285
Scott, P.; Trinchieri, G. 1997: IL-12 as an adjuvant for cell-mediated immunity. Seminars in Immunology 9(5): 285-291
Schwarting, A.; Tesch, G.; Kinoshita, K.; Maron, R.; Weiner, H.L.; Kelley, V.R. 1999: IL-12 drives IFN-gamma-dependent autoimmune kidney disease in MRL-Fas(lpr) mice. Journal of Immunology 163(12): 6884-6891
Rotman, H.L.; Schnyder-Candrian, S.; Scott, P.; Nolan, T.J.; Schad, G.A.; Abraham, D. 1997: IL-12 eliminates the Th-2 dependent protective immune response of mice to larval Strongyloides stercoralis. Parasite Immunology 19(1): 29-39
Xu, H.; Kurihara, H.; Ito, T.; Nakajima, S.; Hagiwara, E.; Yamanokuchi, H.; Asari, A. 2001: IL-12 enhances lymphoaccumulation by suppressing cell death of T cells in MRL- lpr/lpr mice. Journal of Autoimmunity 16(2): 87-95
Anonymous 1999: IL-12 for hepatitis C. TreatmentUpdate 11(6): 2-3
Tahara, H.; Lotze, M.T.; Robbins, P.D.; Storkus, W.J.; Zitvogel, L. 1995: IL-12 gene therapy using direct injection of tumors with genetically engineered autologous fibroblasts. Human Gene Therapy 6(12): 1607-1624
Yang, J.; Qian, Q.; Xue, H.; Cao, H.; Cui, Z.; Shi, W.; Yang, G.; Wu, M. 1999: IL-12 gene treatment of hepatocellular carcinoma: experimental study. Zhonghua Wai Ke Za Zhi 37(4): 202-204
Hall, S.S. 1994: IL-12 holds promise against cancer, glimmer of AIDS hope. Science 263(5154): 1685-1686
Sinigaglia, F. 2000: IL-12 in lung diseases. Sarcoidosis Vasculitis and Diffuse Lung Diseases: Official Journal of Wasog 17(2): 122-124
Horiuchi, Y.; Nishioka, K. 2002: IL-12 in varicella zoster and herpes simplex virus infection. Journal of Dermatology 29(6): 391-393
Puddu, P.; Fantuzzi, L.; Borghi, P.; Varano, B.; Rainaldi, G.; Guillemard, E.; Malorni, W.; Nicaise, P.; Wolf, S.F.; Belardelli, F.; Gessani, S. 1997: IL-12 induces IFN-gamma expression and secretion in mouse peritoneal macrophages. Journal of Immunology 159(7): 3490-3497
Windhagen, A.; Anderson, D.E.; Carrizosa, A.; Williams, R.E.; Hafler, D.A. 1996: IL-12 induces human T cells secreting IL-10 with IFN-gamma. Journal of Immunology 157(3): 1127-1131
Kawamoto, K.; Paliwal, V.; Ramabhadran, R.; Szczepanik, M.; Tsuji, R.F.; Matsuda, H.; Askenase, P.W. 2000: IL-12 is produced by antigen-presenting cells stimulated with soluble alphabeta TCR and restores impaired T(h)1 responses. International Immunology 12(1): 103-112
Anonymous 2001: IL-12 may be useful for hepatitis C. TreatmentUpdate 13(5): 4-5
Kozar, K.; Kaminski, R.; Giermasz, A.; Basak, G.; Zagozdzon, R.; Rybczynska, J.; Wasik, M.; Lasek, W.; Jakobisiak, M.; Golab, J. 2002: IL-12 or IL-15, unlike IL-2, does not interact with histamine in augmenting cytotoxicity of splenocytes against melanoma cells and YAC-1 cells. Oncology Reports 9(2): 427-431
Kichian, K.; Nestel, F.P.; Kim, D.; Ponka, P.; Lapp, W.S. 1996: IL-12 p40 messenger RNA expression in target organs during acute graft-versus-host disease. Possible involvement of IFN-gamma. Journal of Immunology 157(7): 2851-2856
Lucas, M.L.; Heller, L.; Coppola, D.; Heller, R. 2002: IL-12 plasmid delivery by in vivo electroporation for the successful treatment of established subcutaneous B16.F10 melanoma. Molecular Therapy: the Journal of the American Society of Gene Therapy 5(6): 668-675
Szeliga, J.; Hess, H.; Rüde, E.; Schmitt, E.; Germann, T. 1996: IL-12 promotes cellular but not humoral type Ii collagen-specific Th 1-type responses in C57BL/6 and B10.Q mice and fails to induce arthritis. International Immunology 8(8): 1221-1227
Kawakami, K.; Tohyama, M.; Xie, Q.; Saito, A. 1996: IL-12 protects mice against pulmonary and disseminated infection caused by Cryptococcus neoformans. Clinical and Experimental Immunology 104(2): 208-214
Igarashi, O.; Yamane, H.; Imajoh-Ohmi, S.; Nariuchi, H. 1998: IL-12 receptor (IL-12R) expression and accumulation of IL-12R beta 1 and IL-12R beta 2 mRNAs in CD4+ T cells by costimulation with B7-2 molecules. Journal of Immunology 160(4): 1638-1646
Roy, E.J.; Gawlick, U.; Orr, B.A.; Rund, L.A.; Webb, A.G.; Kranz, D.M. 2000: IL-12 treatment of endogenously arising murine brain tumors. Journal of Immunology 165(12): 7293-7299
Yoshimoto, T.; Takeda, K.; Tanaka, T.; Ohkusu, K.; Kashiwamura, S.; Okamura, H.; Akira, S.; Nakanishi, K. 1998: IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-gamma production. Journal of Immunology 161(7): 3400-3407
Gans, H.A.; Maldonado, Y.; Yasukawa, L.L.; Beeler, J.; Audet, S.; Rinki, M.M.; DeHovitz, R.; Arvin, A.M. 1999: IL-12, IFN-gamma, and T cell proliferation to measles in immunized infants. Journal of Immunology 162(9): 5569-5575
Torigo, S.; Ihara, T.; Kamiya, H. 2000: IL-12, IFN-gamma, and TNF-alpha released from mononuclear cells inhibit the spread of varicella-zoster virus at an early stage of varicella. Microbiology and Immunology 44(12): 1027-1031
Tchórzewski, H.; Krasomski, G.; Biesiada, L.; Głowacka, E.; Banasik, M.; Lewkowicz, P. 2000: IL-12, IL-6 and IFN-gamma production by lymphocytes of pregnant women with rheumatoid arthritis remission during pregnancy. Mediators of Inflammation 9(6): 289-293
Lim, Y.C.; Xie, H.; Come, C.E.; Alexander, S.I.; Grusby, M.J.; Lichtman, A.H.; Luscinskas, F.W. 2001: IL-12, STAT4-dependent up-regulation of CD4(+) T cell core 2 beta-1,6-n-acetylglucosaminyltransferase, an enzyme essential for biosynthesis of P-selectin ligands. Journal of Immunology 167(8): 4476-4484
Davidson, N.J.; Hudak, S.A.; Lesley, R.E.; Menon, S.; Leach, M.W.; Rennick, D.M. 1998: IL-12, but not IFN-gamma, plays a major role in sustaining the chronic phase of colitis in IL-10-deficient mice. Journal of Immunology 161(6): 3143-3149
Hong, K.; Chu, A.; Lúdvíksson, B.R.; Berg, E.L.; Ehrhardt, R.O. 1999: IL-12, independently of IFN-gamma, plays a crucial role in the pathogenesis of a murine psoriasis-like skin disorder. Journal of Immunology 162(12): 7480-7491
Geldhof, A.B.; Moser, M.; De Baetselier, P. 1998: IL-12-activated NK cells recognize B7 costimulatory molecules on tumor cells and autologous dendritic cells. Advances in Experimental Medicine and Biology 451: 203-210
Hussell, T.; Openshaw, P.J. 2000: IL-12-activated NK cells reduce lung eosinophilia to the attachment protein of respiratory syncytial virus but do not enhance the severity of illness in CD8 T cell-immunodeficient conditions. Journal of Immunology 165(12): 7109-7115
Magram, J.; Sfarra, J.; Connaughton, S.; Faherty, D.; Warrier, R.; Carvajal, D.; Wu, C.Y.; Stewart, C.; Sarmiento, U.; Gately, M.K. 1996: IL-12-deficient mice are defective but not devoid of type 1 cytokine responses. Annals of the new York Academy of Sciences 795: 60-70
Magram, J.; Connaughton, S.E.; Warrier, R.R.; Carvajal, D.M.; Wu, C.Y.; Ferrante, J.; Stewart, C.; Sarmiento, U.; Faherty, D.A.; Gately, M.K. 1996: IL-12-deficient mice are defective in IFN gamma production and type 1 cytokine responses. Immunity 4(5): 471-481
Le Hir, M.; Ryffel, B.; Schatzmann, U. 2001: IL-12-dependent, INF-gamma-independent experimental glomerulonephritis. Kidney and Blood Pressure Research 24(1): 27-32
Zitvogel, L.; Couderc, B.; Mayordomo, J.I.; Robbins, P.D.; Lotze, M.T.; Storkus, W.J. 1996: IL-12-engineered dendritic cells serve as effective tumor vaccine adjuvants in vivo. Annals of the new York Academy of Sciences 795: 284-293
Müller, U.; Köhler, G.; Mossmann, H.; Schaub, G.A.; Alber, G.; Di Santo, J.P.; Brombacher, F.; Hölscher, C. 2001: IL-12-independent IFN-gamma production by T cells in experimental Chagas' disease is mediated by IL-18. Journal of Immunology 167(6): 3346-3353
Xing, Z.; Zganiacz, A.; Wang, J.; Divangahi, M.; Nawaz, F. 2000: IL-12-independent Th1-type immune responses to respiratory viral infection: requirement of IL-18 for IFN-gamma release in the lung but not for the differentiation of viral-reactive Th1-type lymphocytes. Journal of Immunology 164(5): 2575-2584
Takeuchi, E.; Yanagawa, H.; Suzuki, Y.; Shinkawa, K.; Ohmoto, Y.; Bando, H.; Sone, S. 2002: IL-12-induced production of IL-10 and interferon-gamma by mononuclear cells in lung cancer-associated malignant pleural effusions. Lung Cancer 35(2): 171-177
Poggi, A.; Zocchi, M.R.; Costa, P.; Ferrero, E.; Borsellino, G.; Placido, R.; Galgani, S.; Salvetti, M.; Gasperini, C.; Ristori, G.; Brosnan, C.F.; Battistini, L. 1999: IL-12-mediated NKRP1A up-regulation and consequent enhancement of endothelial transmigration of V delta 2+ TCR gamma delta+ T lymphocytes from healthy donors and multiple sclerosis patients. Journal of Immunology 162(7): 4349-4354
Ozenci, V.; Pashenkov, M.; Kouwenhoven, M.; Rinaldi, L.; Söderström, M.; Link, H. 2001: IL-12/IL-12R system in multiple sclerosis. Journal of Neuroimmunology 114(1-2): 242-252
Stober, D.; Schirmbeck, R.; Reimann, J. 2001: IL-12/IL-18-dependent IFN-gamma release by murine dendritic cells. Journal of Immunology 167(2): 957-965
Wigginton, J.M.; Wiltrout, R.H. 2002: IL-12/IL-2 combination cytokine therapy for solid tumours: translation from bench to bedside. Expert Opinion on Biological Therapy 2(5): 513-524
Abdi, K. 2002: IL-12: the role of p40 versus p75. Scandinavian Journal of Immunology 56(1): 1-11
Bailer, R.T.; Holloway, A.; Sun, J.; Margolick, J.B.; Martin, M.; Kostman, J.; Montaner, L.J. 1999: IL-13 and IFN-gamma secretion by activated T cells in HIV-1 infection associated with viral suppression and a lack of disease progression. Journal of Immunology 162(12): 7534-7542
Rosenwasser, L.J. 2000: IL-13 genetics: pale rider or horse of a different color?. Journal of Allergy and Clinical Immunology 105(3): 430-431
Lopez, M.; Amorim, L.; Gane, P.; Cristoph, A.; Bardinet, D.; Abina, A.M.; Minty, A.; Bernard, J. 1997: IL-13 induces CD34+ cells isolated from G-CSF mobilized blood to differentiate in vitro into potent antigen presenting cells. Journal of Immunological Methods 208(2): 117-129
Mattes, J.; Yang, M.; Siqueira, A.; Clark, K.; MacKenzie, J.; McKenzie, A.N.; Webb, D.C.; Matthaei, K.I.; Foster, P.S. 2001: IL-13 induces airways hyperreactivity independently of the IL-4R alpha chain in the allergic lung. Journal of Immunology 167(3): 1683-1692
Sozzani, P.; Hasan, L.; Séguélas, M.H.; Caput, D.; Ferrara, P.; Pipy, B.; Cambon, C. 1998: IL-13 induces tyrosine phosphorylation of phospholipase C gamma-1 following IRS-2 association in human monocytes: relationship with the inhibitory effect of IL-13 on ROI production. Biochemical and Biophysical Research Communications 244(3): 665-670
Hoshino, T.; Winkler-Pickett, R.T.; Mason, A.T.; Ortaldo, J.R.; Young, H.A. 1999: IL-13 production by NK cells: IL-13-producing NK and T cells are present in vivo in the absence of IFN-gamma. Journal of Immunology 162(1): 51-59
Muchamuel, T.; Menon, S.; Pisacane, P.; Howard, M.C.; Cockayne, D.A. 1997: IL-13 protects mice from lipopolysaccharide-induced lethal endotoxemia: correlation with down-modulation of TNF-alpha, IFN-gamma, and IL-12 production. Journal of Immunology 158(6): 2898-2903
Kim, C-Hoon.; Song, K.Seob.; Koo, J.Seok.; Kim, H-Ung.; Cho, J.Young.; Kim, H.Jun.; Yoon, J-Heon. 2002: IL-13 suppresses MUC5AC gene expression and mucin secretion in nasal epithelial cells. Acta Oto-Laryngologica 122(6): 638-643
Manna, S.K.; Aggarwal, B.B. 1998: IL-13 suppresses TNF-induced activation of nuclear factor-kappa B, activation protein-1, and apoptosis. Journal of Immunology 161(6): 2863-2872
Urban, J.; Fang, H.; Liu, Q.; Ekkens, M.J.; Chen, S.J.; Nguyen, D.; Mitro, V.; Donaldson, D.D.; Byrd, C.; Peach, R.; Morris, S.C.; Finkelman, F.D.; Schopf, L.; Gause, W.C. 2000: IL-13-mediated worm expulsion is B7 independent and IFN-gamma sensitive. Journal of Immunology 164(8): 4250-4256
Asadullah, K.; Haeussler-Quade, A.; Gellrich, S.; Hanneken, S.; Hansen-Hagge, T.E.; Döcke, W.D.; Volk, H.D.; Sterry, W. 2000: IL-15 and IL-16 overexpression in cutaneous T-cell lymphomas: stage-dependent increase in mycosis fungoides progression. Experimental Dermatology 9(4): 248-251
Mueller, Y.M.; Bojczuk, P.M.; Halstead, E.S.; Kim, A.H.J.; Witek, J.; Altman, J.D.; Katsikis, P.D. 2003: IL-15 enhances survival and function of HIV-specific CD8+ T cells. Blood 101(3): 1024-1029
Mueller, Y.M.; Makar, V.; Bojczuk, P.M.; Witek, J.; Katsikis, P.D. 2003: IL-15 enhances the function and inhibits CD95/Fas-induced apoptosis of human CD4+ and CD8+ effector-memory T cells. International Immunology 15(1): 49-58
García, V.E.; Jullien, D.; Song, M.; Uyemura, K.; Shuai, K.; Morita, C.T.; Modlin, R.L. 1998: IL-15 enhances the response of human gamma delta T cells to nonpeptide [correction of nonpetide] microbial antigens. Journal of Immunology 160(9): 4322-4329
Weng, N.-P.; Liu, K.; Catalfamo, M.; Li, Y.; Henkart, P.A. 2002: IL-15 is a growth factor and an activator of CD8 memory T cells. Annals of the new York Academy of Sciences 975: 46-56
Nishimura, H.; Hiromatsu, K.; Kobayashi, N.; Grabstein, K.H.; Paxton, R.; Sugamura, K.; Bluestone, J.A.; Yoshikai, Y. 1996: IL-15 is a novel growth factor for murine gamma delta T cells induced by Salmonella infection. Journal of Immunology 156(2): 663-669
Losy, J.; Niezgoda, A.; Zaremba, J.ła. 2002: IL-15 is elevated in sera of patients with relapsing-remitting multiple sclerosis. Folia Neuropathologica 40(3): 151-153
Avice, M.N.; Demeure, C.E.; Delespesse, G.; Rubio, M.; Armant, M.; Sarfati, M. 1998: IL-15 promotes IL-12 production by human monocytes via T cell-dependent contact and may contribute to IL-12-mediated IFN-gamma secretion by CD4+ T cells in the absence of TCR ligation. Journal of Immunology 161(7): 3408-3415
Lai, Y.G.; Gelfanov, V.; Gelfanova, V.; Kulik, L.; Chu, C.L.; Jeng, S.W.; Liao, N.S. 1999: IL-15 promotes survival but not effector function differentiation of CD8+ TCRalphabeta+ intestinal intraepithelial lymphocytes. Journal of Immunology 163(11): 5843-5850
Plunkett, F.J.; Akbar, A.N. 2001: IL-15--friend or foe in transplantation rejection?. Transplantation 72(5): 771
Ohta, N.; Hiroi, T.; Kweon, M.-N.; Kinoshita, N.; Jang, M.H.; Mashimo, T.; Miyazaki, J.-I.; Kiyono, H. 2002: IL-15-dependent activation-induced cell death-resistant Th1 type CD8 alpha beta+NK1.1+ T cells for the development of small intestinal inflammation. Journal of Immunology 169(1): 460-468
Pereno, R.; Gaggero, A.; Scudeletti, M.; Lanza, L.; Meazza, R.; Mishal, Z.; Jasmin, C.; Indiveri, F.; Ferrini, S.; Azzarone, B. 1999: IL-15/IL-15R alpha intracellular trafficking in human cells and protection from apoptosis. Annals of the new York Academy of Sciences 876: 236-245
Tagaya, Y.; Bamford, R.N.; DeFilippis, A.P.; Waldmann, T.A. 1996: IL-15: a pleiotropic cytokine with diverse receptor/signaling pathways whose expression is controlled at multiple levels. Immunity 4(4): 329-336
Viglianti, G.A.; Parada, N.A.; Maciaszek, J.W.; Kornfeld, H.; Center, D.M.; Cruikshank, W.W. 1997: IL-16 anti-HIV-1 therapy. Nature Medicine 3(9): 938
Chabaud, M.; Lubberts, E.; Joosten, L.; van Den Berg, W.; Miossec, P. 2001: IL-17 derived from juxta-articular bone and synovium contributes to joint degradation in rheumatoid arthritis. Arthritis Research 3(3): 168-177
Hsieh, H.G.; Loong, C.C.; Lui, W.Y.; Chen, A.; Lin, C.Y. 2001: IL-17 expression as a possible predictive parameter for subclinical renal allograft rejection. Transplant International: Official Journal of the European Society for Organ Transplantation 14(5): 287-298
Albanesi, C.; Cavani, A.; Girolomoni, G. 1999: IL-17 is produced by nickel-specific T lymphocytes and regulates ICAM-1 expression and chemokine production in human keratinocytes: synergistic or antagonist effects with IFN-gamma and TNF-alpha. Journal of Immunology 162(1): 494-502
Witowski, J.; Pawlaczyk, K.; Breborowicz, A.; Scheuren, A.; Kuzlan-Pawlaczyk, M.; Wisniewska, J.; Polubinska, A.; Friess, H.; Gahl, G.M.; Frei, U.; Jörres, A. 2000: IL-17 stimulates intraperitoneal neutrophil infiltration through the release of GRO alpha chemokine from mesothelial cells. Journal of Immunology 165(10): 5814-5821
Jovanovic, D.V.; Di Battista, J.A.; Martel-Pelletier, J.; Jolicoeur, F.C.; He, Y.; Zhang, M.; Mineau, F.; Pelletier, J.P. 1998: IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages. Journal of Immunology 160(7): 3513-3521
Bohn, E.; Sing, A.; Zumbihl, R.; Bielfeldt, C.; Okamura, H.; Kurimoto, M.; Heesemann, J.; Autenrieth, I.B. 1998: IL-18 (IFN-gamma-inducing factor) regulates early cytokine production in, and promotes resolution of, bacterial infection in mice. Journal of Immunology 160(1): 299-307
Tsutsui, H.; Matsui, K.; Kawada, N.; Hyodo, Y.; Hayashi, N.; Okamura, H.; Higashino, K.; Nakanishi, K. 1997: IL-18 accounts for both TNF-alpha- and Fas ligand-mediated hepatotoxic pathways in endotoxin-induced liver injury in mice. Journal of Immunology 159(8): 3961-3967
Kalina, U.; Kauschat, D.; Koyama, N.; Nuernberger, H.; Ballas, K.; Koschmieder, S.; Bug, G.; Hofmann, W.K.; Hoelzer, D.; Ottmann, O.G. 2000: IL-18 activates STAT3 in the natural killer cell line 92, augments cytotoxic activity, and mediates IFN-gamma production by the stress kinase p38 and by the extracellular regulated kinases p44erk-1 and p42erk-21. Journal of Immunology 165(3): 1307-1313
Walker, W.; Aste-Amezaga, M.; Kastelein, R.A.; Trinchieri, G.; Hunter, C.A. 1999: IL-18 and CD28 use distinct molecular mechanisms to enhance NK cell production of IL-12-induced IFN-gamma. Journal of Immunology 162(10): 5894-5901
Kashiwamura, S.; Okamura, H. 1998: IL-18 and IL-18 receptor. Nihon Rinsho. Japanese Journal of Clinical Medicine 56(7): 1798-1806
Bossù, P.; Del Giudice, E.; Ciaramella, A.; Neumann, D.; Boraschi, D. 2000: IL-18 and IL-18 receptors in the development of autoimmunity. European Cytokine Network 11(3): 515-516
Nakanishi, K.; Tsutsui, H.; Yoshimoto, T. 2002: IL-18 and atopic inflammation. Tanpakushitsu Kakusan Koso. Protein Nucleic Acid Enzyme 47(16 Suppl): 2362-2368
Kawakami, K.; Koguchi, Y.; Qureshi, M.H.; Miyazato, A.; Yara, S.; Kinjo, Y.; Iwakura, Y.; Takeda, K.; Akira, S.; Kurimoto, M.; Saito, A. 2000: IL-18 contributes to host resistance against infection with Cryptococcus neoformans in mice with defective IL-12 synthesis through induction of IFN-gamma production by NK cells. Journal of Immunology 165(2): 941-947
Shi, F.D.; Takeda, K.; Akira, S.; Sarvetnick, N.; Ljunggren, H.G. 2000: IL-18 directs autoreactive T cells and promotes autodestruction in the central nervous system via induction of IFN-gamma by NK cells. Journal of Immunology 165(6): 3099-3104
Lauw, F.N.; Branger, J.; Florquin, S.; Speelman, P.; van Deventer, S.J.H.; Akira, S.; van der Poll, T. 2002: IL-18 improves the early antimicrobial host response to pneumococcal pneumonia. Journal of Immunology 168(1): 372-378
Losy, J.; Niezgoda, A. 2001: IL-18 in patients with multiple sclerosis. Acta Neurologica Scandinavica 104(3): 171-173
Blease, K.; Kunkel, S.L.; Hogaboam, C.M. 2001: IL-18 modulates chronic fungal asthma in a murine model; putative involvement of Toll-like receptor-2. Inflammation Research: Official Journal of the European Histamine Research Society . 50(11): 552-560
Kawakami, K.; Qureshi, M.H.; Zhang, T.; Okamura, H.; Kurimoto, M.; Saito, A. 1997: IL-18 protects mice against pulmonary and disseminated infection with Cryptococcus neoformans by inducing IFN-gamma production. Journal of Immunology 159(11): 5528-5534
Faggioni, R.; Cattley, R.C.; Guo, J.; Flores, S.; Brown, H.; Qi, M.; Yin, S.; Hill, D.; Scully, S.; Chen, C.; Brankow, D.; Lewis, J.; Baikalov, C.; Yamane, H.; Meng, T.; Martin, F.; Hu, S.; Boone, T.; Senaldi, G. 2001: IL-18-binding protein protects against lipopolysaccharide- induced lethality and prevents the development of Fas/Fas ligand-mediated models of liver disease in mice. Journal of Immunology 167(10): 5913-5920
Suska, F.; Esposito, M.; Gretzer, C.; Källtorp, M.; Tengvall, P.; Thomsen, P. 2003: IL-1alpha, IL-1beta and TNF-alpha secretion during in vivo/ex vivo cellular interactions with titanium and copper. Biomaterials 24(3): 461-468
Rühl, A.; Franzke, S.; Stremmel, W. 2001: IL-1beta and IL-10 have dual effects on enteric glial cell proliferation. Neurogastroenterology and Motility: the Official Journal of the European Gastrointestinal Motility Society 13(1): 89-94
Maass, D.L.; White, J.; Horton, J.W. 2002: IL-1beta and IL-6 act synergistically with TNF-alpha to alter cardiac contractile function after burn trauma. Shock 18(4): 360-366
Kelles, A.; Janssens, J.; Tack, J. 2000: IL-1beta and IL-6 excite neurones and suppress cholinergic neurotransmission in the myenteric plexus of the guinea pig. Neurogastroenterology and Motility: the Official Journal of the European Gastrointestinal Motility Society 12(6): 531-538
Yokoo, T.; Kitamura, M. 1997: IL-1beta depresses expression of the 70-kilodalton heat shock protein and sensitizes glomerular cells to oxidant-initiated apoptosis. Journal of Immunology 159(6): 2886-2892
Noguchi, T.; Noguchi, M.; Masubuchi, H.; Seki, T.; Ariga, T. 2001: IL-1beta down-regulates tissue-type plasminogen activator by up-regulating low-density lipoprotein receptor-related protein in AML 12 cells. Biochemical and Biophysical Research Communications 288(1): 42-48
Ogura, N.; Tobe, M.; Tamaki, H.; Nagura, H.; Abiko, Y. 2001: IL-1beta increases uPA and uPA receptor expression in human gingival fibroblasts. Iubmb Life 51(6): 381-385
Parikh, A.A.; Moon, M.R.; Pritts, T.A.; Fischer, J.E.; Szabó, C.; Hasselgren, P.O.; Salzman, A.L. 2000: IL-1beta induction of NF-kappaB activation in human intestinal epithelial cells is independent of oxyradical signaling. Shock 13(1): 8-13
Grutkoski, P.S.; D'Amico, R.; Ayala, A.; Simms, H.H. 1999: IL-1beta stimulation induces paracrine regulation of PMN function and apoptosis. Shock 12(5): 373-381
Jablonska, E.; Jablonski, J.; Piotrowski, L.; Grabowska, Z. 2001: IL-1beta, IL-1Ra and sIL-1RII in the culture supernatants of PMN and PBMC and the serum levels in patients with inflammation and patients with cancer disease of the same location. Immunobiology 204(4): 508-516
Osiri, M.; Ruxrungtham, K.; Nookhai, S.; Ohmoto, Y.; Deesomchok, U. 1998: IL-1beta, IL-6 and TNF-alpha in synovial fluid of patients with non-gonococcal septic arthritis. Asian Pacific Journal of Allergy and Immunology 16(4): 155-160
Neumann, D.; Lienenklaus, S.; Rosati, O.; Martin, M.U. 2002: IL-1beta-induced phosphorylation of PKB/Akt depends on the presence of IRAK-1. European Journal of Immunology 32(12): 3689-3698
Vincent, J.L.; Slotman, G.; Van Leeuwen, P.A.; Shelly, M.; Nasraway, S.; Tenaillon, A.; Bander, J.; Friedman, G. 1999: IL-1ra administration does not improve cardiac function in patients with severe sepsis. Journal of Critical Care 14(2): 69-72
Heesen, C.; Sieverding, F.; Buhmann, C.; Gbadamosi, J. 2000: IL-1ra serum levels in disease stages of MS--a marker for progression?. Acta Neurologica Scandinavica 101(2): 95-97
Marsh, C.B.; Moore, S.A.; Pope, H.A.; Wewers, M.D. 1994: IL-1ra suppresses endotoxin-induced IL-1 beta and TNF-alpha release from mononuclear phagocytes. American Journal of Physiology 267(1 Part 1): L39-L45
Hong, M.A.; Wakim, V.L.; Salomão, S.J.; Camargo, L.S.; Casseb, J.; Duarte, A.J. 1998: IL-2 and IFN-gamma, but not IL-4 secretion by peripheral blood mononuclear cells (PBMC) are related to CD4+ T cells and clinical status in Brazilian HIV-1-infected subjects. Revista do Instituto de Medicina Tropical de Sao Paulo 40(6): 351-354
Sírová, M.; Ríhová, B.; Ríha, I.; Leipner, C. 1993: IL-2 and IL-3 production in high and low IgG-responding strains of mice. Immunology Letters 37(1): 91-96
Nishizawa, K.; Koyasu, S. 1997: IL-2 and IL-7 differentially induce CD4-CD8- alpha beta TCR+NK1.1+ large granular lymphocytes and IL-4-producing cells from CD4-CD8- alpha beta TCR+NK1.1- cells: implications for the regulation of Th1- and Th2-type responses. International Immunology 9(8): 1123-1129
Sharief, M.K. 1993: IL-2 and MS. Neurology 43(7): 1449-1450
Chyczewska, E.; Mróz, R.M.; Kowal, E. 1997: IL-2 concentration in bronchoalveolar lavage fluid (BALF) of non-small cell lung cancer (NSCLC) patients. Roczniki Akademii Medycznej W Bialymstoku 42(Suppl 1): 136-145
Bathe, O.F.; Dalyot-Herman, N.; Malek, T.R. 2001: IL-2 during in vitro priming promotes subsequent engraftment and successful adoptive tumor immunotherapy by persistent memory phenotypic CD8(+) T cells. Journal of Immunology 167(8): 4511-4517
Highleyman, L. 1999: IL-2 flushes out HIV. Beta: Bulletin of Experimental Treatments for Aids: a Publication of the San Francisco Aids Foundation 12(1): 4
Sterritt, C. 1997: IL-2 for HIV: the long march toward FDA approval. Food and Drug Administration. Gmhc Treatment Issues: the Gay Men's Health Crisis Newsletter of Experimental Aids Therapies 11(9): 1-3
Liu, S.; Lin, Y.; Tang, S.; Yang, H.; Liang, C. 2001: IL-2 gene and cisplatin combined therapy for head and neck squamous cell carcinoma. Hua Xi Kou Qiang Yi Xue Za Zhi 19(3): 191-193
Stein, U.; Walther, W.; Shoemaker, R.H.; Schlag, P.M. 1998: IL-2 gene transfer for chemosensitization of multidrug-resistant human colon carcinoma cells. Advances in Experimental Medicine and Biology 451: 145-149
Indrová, M.; Pajtasz-Piasecka, E.; Jandlová, T.; Símová, J.; Bubeník, J.; Radzikowski, C. 1999: IL-2 gene-modified tumour vaccines: monitoring of IL-2 levels in serum and peritoneal cavity of vaccinated mice. Folia Biologica 45(1): 7-11
Guarini, A.; Gansbacher, B.; Cronin, K.; Fierro, M.T.; Foa, R. 1995: IL-2 gene-transduced human HLA-A2 melanoma cells can generate a specific antitumor cytotoxic T-lymphocyte response. Cytokines and Molecular Therapy 1(1): 57-64
Lissoni, P.; Bucovec, R.; Meregalli, S.; Fumagalli, L.; Vigorè, L.; Ferrante, R.; Brivio, F. 1999: IL-2 immunotherapy-induced increase in IL-12 blood concentrations may depend on an increase in circulating dendritic cell number. International Journal of Biological Markers 14(3): 195-197
Atzpodien, J.; Kirchner, H.; Illiger, H.J.; Metzner, B.; Ukena, D.; Schott, H.; Funke, P.J.; Gramatzki, M.; Jürgenson, S.; Wandert, T.; Patzelt, T.; Reitz, M. 2001: IL-2 in combination with IFN- alpha and 5-FU versus tamoxifen in metastatic renal cell carcinoma: long-term results of a controlled randomized clinical trial. British Journal of Cancer 85(8): 1130-1136
Wang, K.S.; Ritz, J.; Frank, D.A. 1999: IL-2 induces STAT4 activation in primary NK cells and NK cell lines, but not in T cells. Journal of Immunology 162(1): 299-304
Nielsen, M.; Svejgaard, A.; Skov, S.; Dobson, P.; Bendtzen, K.; Geisler, C.; Odum, N. 1996: IL-2 induces beta2-integrin adhesion via a wortmannin/LY294002-sensitive, rapamycin-resistant pathway. Phosphorylation of a 125-kilodalton protein correlates with induction of adhesion, but not mitogenesis. Journal of Immunology 157(12): 5350-5358
Anonymous 1997: IL-2 injections boost CD4 cells. Aids Alert 12(6): 69
Anonymous 1998: IL-2 plus HAART reduces HIV in immune system "hiding places". World 1998(No 92): 7
Rayon, C. 1997: IL-2 post-autologous transplant of hematopoietic stem cells. Sangre 42(Suppl 1): 37
Demaison, C.; Fiette, L.; Blanchetière, V.; Schimpl, A.; Thèze, J.; Froussard, P. 1998: IL-2 receptor alpha-chain expression is independently regulated in primary and secondary lymphoid organs. Journal of Immunology 161(4): 1977-1982
McIntosh, R.S.; Tandon, N.; Pickerill, A.P.; Davies, R.; Barnett, D.; Weetman, A.P. 1993: IL-2 receptor-positive intrathyroidal lymphocytes in Graves' disease. Analysis of V alpha transcript microheterogeneity. Journal of Immunology 151(7): 3884-3893
Rinfret, A.; Anderson, S.K. 1993: IL-2 regulates the expression of the NK-TR gene via an alternate RNA splicing mechanism. Molecular Immunology 30(14): 1307-1313
Grodeck, B. 1995: IL-2 restores immune sytem. Positively Aware: the Monthly Journal of the Test Positive Aware Network 1995: 8
Gómez, J.; García, A.; R-Borlado, L.; Bonay, P.; Martínez-A, C.; Silva, A.; Fresno, M.; Carrera, A.C.; Eicher-Streiber, C.; Rebollo, A. 1997: IL-2 signaling controls actin organization through Rho-like protein family, phosphatidylinositol 3-kinase, and protein kinase C-zeta. Journal of Immunology 158(4): 1516-1522
Anonymous 1999: IL-2 study results in confusion. TreatmentUpdate 11(5): 4-6
Anonymous 2001: IL-2 study web site available. Aids Patient Care and Stds 15(4): 230
Gilden, D. 1999: IL-2 taken to HAART. Gmhc Treatment Issues: the Gay Men's Health Crisis Newsletter of Experimental Aids Therapies 13(2): 4-6
Grundström, S.; Dohlsten, M.; Sundstedt, A. 2000: IL-2 unresponsiveness in anergic CD4+ T cells is due to defective signaling through the common gamma-chain of the IL-2 receptor. Journal of Immunology 164(3): 1175-1184
Anonymous 1997: IL-2 update. PI perspective 1997(No 21): 17
Anonymous 1998: IL-2 without antiretroviral therapy, trial near Wash. D.C. AIDS treatment news 1998(No 290): 7
Lin, J.; Li, L.; Gao, Y.; Min, B.; Xu, X. 1997: IL-2, IFN-gamma, and TNF-alpha mRNA expression in peripheral blood mononuclear cells in patients with multiple sclerosis. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. Acta Academiae Medicinae Sinicae 19(1): 24-28
Li, Y.; Chen, B.; Qiu, C.C. 1996: IL-2, IL-2R mRNA gene expression and protein production. Zhonghua Yi Xue Za Zhi 76(7): 505-508
Royuela, M.; De Miguel, M.P.; Bethencourt, F.R.; Fraile, B.; Arenas, M.I.; Paniagua, R. 2000: IL-2, its receptors, and bcl-2 and bax genes in normal, hyperplastic and carcinomatous human prostates: immunohistochemical comparative analysis. Growth Factors 18(2): 135-146
Su, H.C.; Orange, J.S.; Fast, L.D.; Chan, A.T.; Simpson, S.J.; Terhorst, C.; Biron, C.A. 1994: IL-2-dependent NK cell responses discovered in virus-infected beta 2-microglobulin-deficient mice. Journal of Immunology 153(12): 5674-5681
Agostini, M.; Di Marco, B.; Spinicelli, S.; Bruscoli, S.; Delfino, D.V. 2001: IL-2-driven natural killer cell generation: role of anti-H-2b monoclonal antibodies and stromal cells in controlling quantitative and repertoire changes. Journal of ChemoTherapy 13(5): 527-534
Iacobelli, M.; Rohwer, F.; Shanahan, P.; Quiroz, J.A.; McGuire, K.L. 1999: IL-2-mediated cell cycle progression and inhibition of apoptosis does not require NF-kappa B or activating protein-1 activation in primary human T cells. Journal of Immunology 162(6): 3308-3315
Robinet, E.; Fournel, S.; Fatmi, A.; Revillard, J.P. 1996: IL-2-resistant hyporesponsiveness induced by CD4 mAbs in OKT3-activated human T cells is reversed by CD45RA triggering. Cellular Immunology 167(1): 1-7
Frucht, D.M. 2002: IL-23: a cytokine that acts on memory T cells. Science's Stke: Signal Transduction Knowledge Environment 114: Pe1
James, J.S. 1996: IL-2: controlled trial finds major CD4 increases. Aids Treatment News 1996(No 258: 3-4
Eicher, D.M.; Waldmann, T.A. 1998: IL-2R alpha on one cell can present IL-2 to IL-2R beta/gamma(c) on another cell to augment IL-2 signaling. Journal of Immunology 161(10): 5430-5437
Eckenberg, R.; Moreau, J.L.; Melnyk, O.; Thèze, J. 2000: IL-2R beta agonist P1-30 acts in synergy with IL-2, IL-4, IL-9, and IL-15: biological and molecular effects. Journal of Immunology 165(8): 4312-4318
Phillips, K.E.; Herring, B.; Wilson, L.A.; Rickford, M.S.; Zhang, M.; Goldman, C.K.; Tso, J.Y.; Waldmann, T.A. 2000: IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction. Cancer Research 60(24): 6977-6984
Porter, B.O.; Malek, T.R. 1999: IL-2Rbeta/IL-7Ralpha doubly deficient mice recapitulate the thymic and intraepithelial lymphocyte (IEL) developmental defects of gammac-/- mice: roles for both IL-2 and IL-15 in CD8alphaalpha IEL development. Journal of Immunology 163(11): 5906-5912
Chen, Q.; Solar, G.; Eaton, D.L.; de Sauvage, F.J. 1998: IL-3 does not contribute to platelet production in c-Mpl-deficient mice. Stem Cells 16 Suppl. 2: 31-36
Crooks, G.M.; Hao, Q.L.; Petersen, D.; Barsky, L.W.; Bockstoce, D. 2000: IL-3 increases production of B lymphoid progenitors from human CD34+CD38- cells. Journal of Immunology 165(5): 2382-2389
Ackermann, L.W.; Wollenweber, L.A.; Denning, G.M. 1999: IL-4 and IFN-gamma increase steady state levels of polymeric Ig receptor mRNA in human airway and intestinal epithelial cells. Journal of Immunology 162(9): 5112-5118
Hofman, T. 1995: IL-4 and IFN-gamma level in blood serum of children with food allergy. Roczniki Akademii Medycznej W Bialymstoku 40(3): 462-467
Van Den Broek, M.; Bachmann, M.F.; Köhler, G.; Barner, M.; Escher, R.; Zinkernagel, R.; Kopf, M. 2000: IL-4 and IL-10 antagonize IL-12-mediated protection against acute vaccinia virus infection with a limited role of IFN-gamma and nitric oxide synthetase 2. Journal of Immunology 164(1): 371-378
Poe, J.C.; Wagner, D.H.; Miller, R.W.; Stout, R.D.; Suttles, J. 1997: IL-4 and IL-10 modulation of CD40-mediated signaling of monocyte IL-1beta synthesis and rescue from apoptosis. Journal of Immunology 159(2): 846-852
Palmer-Crocker, R.L.; Hughes, C.C.; Pober, J.S. 1996: IL-4 and IL-13 activate the JAK2 tyrosine kinase and Stat6 in cultured human vascular endothelial cells through a common pathway that does not involve the gamma c chain. Journal of Clinical Investigation 98(3): 604-609
Hatzistilianou, M.; Aggouridaki, C.; Catriu, D.; Athanassiadou, F. 1996: IL-4 and SCD23 in children with atopic dermatitis. European Journal of Pediatrics 155(6): 521-522
Wadhwa, M.; Dilger, P.; Meager, A.; Walker, B.; Gaines-Das, R.; Thorpe, R. 1996: IL-4 and TNF-alpha-mediated proliferation of the human megakaryocytic line M-O7E is regulated by induced autocrine production of GM-CSF. Cytokine 8(12): 900-909
Trompezinski, S.; Denis, A.; Vinche, A.; Schmitt, D.; Viac, J. 2002: IL-4 and interferon-gamma differentially modulate vascular endothelial growth factor release from normal human keratinocytes and fibroblasts. Experimental Dermatology 11(3): 224-231
Nogawa, S. 1996: IL-4 and tumor immunity. Fukuoka Igaku Zasshi 87(1): 8-13
Coyle, A.J.; Bertrand, C.; Tsuyuki, S.; Pircher, H.; Walti, S.; Le Gros, G.; Erard, F. 1996: IL-4 differentiates naive CD8+ T cells to a "Th2-like" phenotype: a link between viral infections and bronchial asthma. Annals of the new York Academy of Sciences 796: 97-103
Cluitmans, F.H.; Esendam, B.H.; Landegent, J.E.; Willemze, R.; Falkenburg, J.H. 1994: IL-4 down-regulates IL-2-, IL-3-, and GM-CSF-induced cytokine gene expression in peripheral blood monocytes. Annals of Hematology 68(6): 293-298
Wang, H.Y.; Paul, W.E.; Keegan, A.D. 1996: IL-4 function can be transferred to the IL-2 receptor by tyrosine containing sequences found in the IL-4 receptor alpha chain. Immunity 4(2): 113-121
Benedetti, S.; Di Meco, F.; Cirenei, N.; Bruzzone, M.G.; Pollo, B.; Florio, N.; Caposio, L.; Colombo, M.P.; Cattaneo, E.; Finocchiaro, G. 1998: IL-4 gene transfer for the treatment of experimental gliomas. Advances in Experimental Medicine and Biology 451: 315-321
Fu, J.; Li, C.; Yang, X.; Li, X. 2000: IL-4 gene transfer induces the differentiation of cells and inhibits the activity of telomerase in hepatoblastoma cells. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 17(2): 87-90
Lingnau, K.; Hoehn, P.; Kerdine, S.; Koelsch, S.; Neudoerfl, C.; Palm, N.; Ruede, E.; Schmitt, E. 1998: IL-4 in combination with TGF-beta favors an alternative pathway of Th1 development independent of IL-12. Journal of Immunology 161(9): 4709-4718
Pearce, E.J.; Vasconcelos, J.P.; Brunet, L.R.; Sabin, E.A. 1996: IL-4 in schistosomiasis. Experimental Parasitology 84(2): 295-299
Jourdan, P.; Abbal, C.; Noraz, N.; Hori, T.; Uchiyama, T.; Vendrell, J.P.; Bousquet, J.; Taylor, N.; Pène, J.; Yssel, H.; Nora, N. 1998: IL-4 induces functional cell-surface expression of CXCR4 on human T cells. Journal of Immunology 160(9): 4153-4157
Ryan, J.J.; DeSimone, S.; Klisch, G.; Shelburne, C.; McReynolds, L.J.; Han, K.; Kovacs, R.; Mirmonsef, P.; Huff, T.F. 1998: IL-4 inhibits mouse mast cell Fc epsilonRi expression through a STAT6-dependent mechanism. Journal of Immunology 161(12): 6915-6923
Bendixen, A.C.; Shevde, N.K.; Dienger, K.M.; Willson, T.M.; Funk, C.D.; Pike, J.W. 2001: IL-4 inhibits osteoclast formation through a direct action on osteoclast precursors via peroxisome proliferator-activated receptor gamma 1. Proceedings of the National Academy of Sciences of the United States of America 98(5): 2443-2448
Levings, M.K.; Schrader, J.W. 1999: IL-4 inhibits the production of TNF-alpha and IL-12 by STAT6-dependent and -independent mechanisms. Journal of Immunology 162(9): 5224-5229
Spinozzi, F.; Nicoletti, I.; Agea, E.; Belia, S.; Moraca, R.; Migliorati, G.; Riccardi, C.; Grignani, F.; Bertotto, A. 1995: IL-4 is able to reverse the CD2-mediated negative apoptotic signal to CD4-CD8- alpha beta and/or gamma delta T lymphocytes. Immunology 86(3): 379-384
Sugawara, I.; Yamada, H.; Mizuno, S.; Iwakura, Y. 2000: IL-4 is required for defense against mycobacterial infection. Microbiology and Immunology 44(12): 971-979
Szalay, G.; Ladel, C.H.; Blum, C.; Kaufmann, S.H. 1996: IL-4 neutralization or TNF-alpha treatment ameliorate disease by an intracellular pathogen in IFN-gamma receptor-deficient mice. Journal of Immunology 157(11): 4746-4750
Bian, Z.M.; Elner, S.G.; Strieter, R.M.; Kunkel, S.L.; Lukacs, N.W.; Elner, V.M. 1999: IL-4 potentiates IL-1beta- and TNF-alpha-stimulated IL-8 and MCP-1 protein production in human retinal pigment epithelial cells. Current Eye Research 18(5): 349-357
Emoto, M.; Emoto, Y.; Kaufmann, S.H. 1995: IL-4 producing CD4+ TCR alpha beta int liver lymphocytes: influence of thymus, beta 2-microglobulin and NK1.1 expression. International Immunology 7(11): 1729-1739
Tori, M.; Ito, T.; Yumiba, T.; Ohkawa, A.; Maeda, A.; Sawai, T.; Kiyomoto, T.; Akamaru, Y.; Miyasaka, M.; Kiyono, H.; Matsuda, H.; Nozawa, M.; Shirakura, R. 1999: IL-4 production in IDDM-nonrecurrent pancreas-transplanted BB rats with donor-derived NKR-P1+TCR alpha beta + (NKT) cells, but not in IDDM-recurrent BB rats. Transplantation Proceedings 31(5): 1940-1941
Cohn, L.; Herrick, C.; Niu, N.; Homer, R.; Bottomly, K. 2001: IL-4 promotes airway eosinophilia by suppressing IFN-gamma production: defining a novel role for IFN-gamma in the regulation of allergic airway inflammation. Journal of Immunology 166(4): 2760-2767
Aguirre, S.A.; Perryman, L.E.; Davis, W.C.; McGuire, T.C. 1998: IL-4 protects adult C57BL/6 mice from prolonged Cryptosporidium parvum infection: analysis of CD4+alpha beta+IFN-gamma+ and CD4+alpha beta+IL-4+ lymphocytes in gut-associated lymphoid tissue during resolution of infection. Journal of Immunology 161(4): 1891-1900
Brunet, L.R.; Finkelman, F.D.; Cheever, A.W.; Kopf, M.A.; Pearce, E.J. 1997: IL-4 protects against TNF-alpha-mediated cachexia and death during acute schistosomiasis. Journal of Immunology 159(2): 777-785
Launois, P.; Maillard, I.; Pingel, S.; Swihart, K.G.; Xénarios, I.; Acha-Orbea, H.; Diggelmann, H.; Locksley, R.M.; MacDonald, H.R.; Louis, J.A. 1997: IL-4 rapidly produced by V beta 4 V alpha 8 CD4+ T cells instructs Th2 development and susceptibility to Leishmania major in BALB/c mice. Immunity 6(5): 541-549
Schnarr, B.; Ezernieks, J.; Sebald, W.; Duschl, A. 1997: IL-4 receptor complexes containing or lacking the gamma C chain are inhibited by an overlapping set of antagonistic IL-4 mutant proteins. International Immunology 9(6): 861-868
Pan, P.Y.; Rothman, P. 1999: IL-4 receptor mutations. Current Opinion in Immunology 11(6): 615-620
Ting, C.C.; Liang, S.M.; Wang, J.; Chen, Y.Y.; Hargrove, M.; Xu, N. 1994: IL-4 regulation of perforin gene expression and BLT-esterase production in alpha CD3-induced activated killer cells. Biotechnology Therapeutics 5(3-4): 99-115
Flesch, I.E.; Wandersee, A.; Kaufmann, S.H. 1997: IL-4 secretion by CD4+ NK1+ T cells induces monocyte chemoattractant protein-1 in early listeriosis. Journal of Immunology 159(1): 7-10
Losman, J.; Chen, X.P.; Jiang, H.; Pan, P.Y.; Kashiwada, M.; Giallourakis, C.; Cowan, S.; Foltenyi, K.; Rothman, P. 1999: IL-4 signaling is regulated through the recruitment of phosphatases, kinases, and SOCS proteins to the receptor complex. Cold Spring Harbor Symposia on Quantitative Biology 64: 405-416
Nies, J.H.; Bär, C.; Schlenvoigt, G.; Fahlbusch, B.; Zwacka, G.; Markert, U.R. 2002: IL-4 supplemented B-cell cultures of allergic children show reduced IgA and IgG production in response to additional stimulation with IL-10. Journal of Investigational Allergology and Clinical Immunology 12(2): 99-106
Ihn, H.; Yamane, K.; Asano, Y.; Kubo, M.; Tamaki, K. 2002: IL-4 up-regulates the expression of tissue inhibitor of metalloproteinase-2 in dermal fibroblasts via the p38 mitogen-activated protein kinase dependent pathway. Journal of Immunology 168(4): 1895-1902
Terada, N.; Konno, A.; Terada, Y.; Fukuda, S.; Yamashita, T.; Abe, T.; Shimada, H.; Ishida, K.; Yoshimura, K.; Tanaka, Y. 1995: IL-4 upregulates Fc epsilon Ri alpha-chain messenger RNA in eosinophils. Journal of Allergy and Clinical Immunology 96(6 Part 2): 1161-1169
Joyce, D.A.; Steer, J.H. 1996: IL-4, IL-10 and IFN-gamma have distinct, but interacting, effects on differentiation-induced changes in TNF-alpha and TNF receptor release by cultured human monocytes. Cytokine 8(1): 49-57
Szczepanik, A.M.; Funes, S.; Petko, W.; Ringheim, G.E. 2001: IL-4, IL-10 and IL-13 modulate a beta(1--42)-induced cytokine and chemokine production in primary murine microglia and a human monocyte cell line. Journal of Neuroimmunology 113(1): 49-62
Young, D.A.; Lowe, L.D.; Booth, S.S.; Whitters, M.J.; Nicholson, L.; Kuchroo, V.K.; Collins, M. 2000: IL-4, IL-10, IL-13, and TGF-beta from an altered peptide ligand-specific Th2 cell clone down-regulate adoptive transfer of experimental autoimmune encephalomyelitis. Journal of Immunology 164(7): 3563-3572
Caproni, M.; Calzolari, A.; Giomi, B.; Santucci, M.; Ficarra, G.; Fabbri, P. 2002: IL-4, IL-5, TGF-beta1 and IFN-gamma mRNAs detected by a new in situ amplification system in cicatricial pemphigoid. Experimental Dermatology 11(5): 421-427
Kakinuma, T.; Nakamura, K.; Wakugawa, M.; Yano, S.; Saeki, H.; Torii, H.; Komine, M.; Asahina, A.; Tamaki, K. 2002: IL-4, but not IL-13, modulates TARC (thymus and activation-regulated chemokine)/CCL17 and IP-10 (interferon-induced protein of 10kDA)/CXCL10 release by TNF-alpha and IFN-gamma in HaCaT cell line. Cytokine 20(1): 1-6
Nguyen, V.T.; Benveniste, E.N. 2000: IL-4-activated STAT-6 inhibits IFN-gamma-induced CD40 gene expression in macrophages/microglia. Journal of Immunology 165(11): 6235-6243
Aronica, M.A.; Goenka, S.; Boothby, M. 2000: IL-4-dependent induction of BCL-2 and BCL-X(L)IN activated T lymphocytes through a STAT6- and pi 3-kinase-independent pathway. Cytokine 12(6): 578-587
Elovic, A.E.; Ohyama, H.; Sauty, A.; McBride, J.; Tsuji, T.; Nagai, M.; Weller, P.F.; Wong, D.T. 1998: IL-4-dependent regulation of TGF-alpha and TGF-beta1 expression in human eosinophils. Journal of Immunology 160(12): 6121-6127
Cohn, L.; Tepper, J.S.; Bottomly, K. 1998: IL-4-independent induction of airway hyperresponsiveness by Th2, but not Th1, cells. Journal of Immunology 161(8): 3813-3816
Ohmori, Y.; Hamilton, T.A. 1997: IL-4-induced STAT6 suppresses IFN-gamma-stimulated STAT1-dependent transcription in mouse macrophages. Journal of Immunology 159(11): 5474-5482
Song, G.Y.; Chung, C.S.; Chaudry, I.H.; Ayala, A. 2000: IL-4-induced activation of the Stat6 pathway contributes to the suppression of cell-mediated immunity and death in sepsis. Surgery 128(2): 133-138
Bronte, V.; Serafini, P.; De Santo, C.; Marigo, I.; Tosello, V.; Mazzoni, A.; Segal, D.M.; Staib, C.; Lowel, M.; Sutter, G.; Colombo, M.P.; Zanovello, P. 2003: IL-4-induced arginase 1 suppresses alloreactive T cells in tumor-bearing mice. Journal of Immunology 170(1): 270-278
Sanz, M.J.; Marinova-Mutafchieva, L.; Green, P.; Lobb, R.R.; Feldmann, M.; Nourshargh, S. 1998: IL-4-induced eosinophil accumulation in rat skin is dependent on endogenous TNF-alpha and alpha 4 integrin/VCAM-1 adhesion pathways. Journal of Immunology 160(11): 5637-5645
Schwaiger, S.; Wolf, A.M.; Robatscher, P.; Jenewein, B.; Grubeck-Loebenstein, B. 2003: IL-4-producing CD8+ T cells with a CD62L++(bright) phenotype accumulate in a subgroup of older adults and are associated with the maintenance of intact humoral immunity in old age. Journal of Immunology 170(1): 613-619
Gerber, D.J.; Azuara, V.; Levraud, J.P.; Huang, S.Y.; Lembezat, M.P.; Pereira, P. 1999: IL-4-producing gamma delta T cells that express a very restricted TCR repertoire are preferentially localized in liver and spleen. Journal of Immunology 163(6): 3076-3082
Lawrence, C.E.; Paterson, J.C.; Higgins, L.M.; MacDonald, T.T.; Kennedy, M.W.; Garside, P. 1998: IL-4-regulated enteropathy in an intestinal nematode infection. European Journal of Immunology 28(9): 2672-2684
Jiang, H.; Harris, M.B.; Rothman, P. 2000: IL-4/IL-13 signaling beyond JAK/STAT. Journal of Allergy and Clinical Immunology 105(6 Part 1): 1063-1070
Kotsimbos, A.T.; Hamid, Q. 1997: IL-5 and IL-5 receptor in asthma. Memorias do Instituto Oswaldo Cruz 92(Suppl 2): 75-91
Martin, C.; Al-Qaoud, K.M.; Ungeheuer, M.N.; Paehle, K.; Vuong, P.N.; Bain, O.; Fleischer, B.; Hoerauf, A. 2000: IL-5 is essential for vaccine-induced protection and for resolution of primary infection in murine filariasis. Medical Microbiology and Immunology 189(2): 67-74
Sampson, A.P. 2001: IL-5 priming of eosinophil function in asthma. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 31(4): 513-517
Kopf, M.; Brombacher, F.; Hodgkin, P.D.; Ramsay, A.J.; Milbourne, E.A.; Dai, W.J.; Ovington, K.S.; Behm, C.A.; Köhler, G.; Young, I.G.; Matthaei, K.I. 1996: IL-5-deficient mice have a developmental defect in CD5+ B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses. Immunity 4(1): 15-24
Hamelmann, E.; Gelfand, E.W. 2001: IL-5-induced airway eosinophilia--the key to asthma?. Immunological Reviews 179: 182-191
Weltman, J.K.; Karim, A.S. 2000: IL-5: biology and potential therapeutic applications. Expert Opinion on Investigational Drugs 9(3): 491-496
Wysocki, P.J.; Kowalczyk, D.W.; Izycki, D.; Grabarczyk, P.; Kwias, Z.; Mackiewicz, A. 2001: IL-6 and GM-CSF in tumor rejection model of renal cell cancer. Advances in Experimental Medicine and Biology 495: 379-383
Kozak, W.; Kluger, M.J.; Soszynski, D.; Conn, C.A.; Rudolph, K.; Leon, L.R.; Zheng, H. 1998: IL-6 and IL-1 beta in fever. Studies using cytokine-deficient (knockout) mice. Annals of the new York Academy of Sciences 856: 33-47
Horton, S.B.; Butt, W.W.; Mullaly, R.J.; Thuys, C.A.; O'Connor, E.B.; Byron, K.; Cochrane, A.D.; Brizard, C.P.; Karl, T.R. 1999: IL-6 and IL-8 levels after cardiopulmonary bypass are not affected by surface coating. Annals of Thoracic Surgery 68(5): 1751-1755
Ferrà, C.; de Sanjosé, S.; Gallardo, D.; Berlanga, J.J.; Rueda, F.; Marìn, D.; de la Banda, E.; Ancìn, I.; Peris, J.; Garcìa, J.; Grañena, A. 1998: IL-6 and IL-8 levels in plasma during hematopoietic progenitor transplantation. Haematologica 83(12): 1082-1087
Kaplanski, G.; Teysseire, N.; Farnarier, C.; Kaplanski, S.; Lissitzky, J.C.; Durand, J.M.; Soubeyrand, J.; Dinarello, C.A.; Bongrand, P. 1995: IL-6 and IL-8 production from cultured human endothelial cells stimulated by infection with Rickettsia conorii via a cell-associated IL-1 alpha-dependent pathway. Journal of Clinical Investigation 96(6): 2839-2844
Holzheimer, R.G.; Molloy, R.G.; Görlach, H.; Wilkert, S.; Hehrlein, F. 1994: IL-6 and TNF alpha release in association with neutrophil activation after cardiopulmonary bypass surgery. Infection 22(1): 37-42
Pałczyński, B.; Chełmońska-Soyta, A.; Zimecki, M.; Banach, E. 2001: IL-6 and TNF-alpha levels in oviductal epithelial cells culture after escherichia coli LPS stimulation. Ginekologia Polska 72(12a): 1334-1339
Yoshizaki, K. 1997: IL-6 and autoimmune diseases. Nihon Rinsho Men'eki Gakkai Kaishi 20(6): 507-509
Senior, K. 1999: IL-6 and gp130 signalling: its role in chronic disease. Molecular Medicine Today 5(7): 283
Stelmasiak, Z.; Kozioł-Montewka, M.; Dobosz, B.; Rejdak, K. 2001: IL-6 and sIL-6R concentration in the cerebrospinal fluid and serum of MS patients. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research 7(5): 914-918
Di Poi, E.; Ferraccioli, G.F. 1999: IL-6 and some natural inhibitors of chronic human inflammation in RA and SLE. Clinical and Experimental Rheumatology 17(4): 513
Kong, B.; Isozaki, T.; Sasaki, S. 1996: IL-6 antisense-mediated growth inhibition of a choriocarcinoma cell line: an intracellular autocrine growth mechanism. Gynecologic Oncology 63(1): 78-84
Armario, A.; Hernández, J.; Bluethmann, H.; Hidalgo, J. 1998: IL-6 deficiency leads to increased emotionality in mice: evidence in transgenic mice carrying a null mutation for IL-6. Journal of Neuroimmunology 92(1-2): 160-169
Xie, P.; Chan, F.S.; Ip, N.Y.; Leung, M.F. 2000: IL-6 enhanced the retinoic acid-induced differentiation of human acute promyelocytic leukemia cells. Cancer Letters 148(2): 207-213
Kikuchi, T.; Ishida, S.; Kinoshita, T.; Sakuma, S.; Sugawara, N.; Yamashita, T.; Koike, K. 2002: IL-6 enhances IgE-dependent histamine release from human peripheral blood-derived cultured mast cells. Cytokine 20(5): 200-209
Zhong, H.; Gu, F.; Yu, L. 1996: IL-6 gene expression in human tumor cell lines. Zhonghua Wai Ke Za Zhi 34(1): 22-24
Song, L.; Li, Y.; Sun, Y.-x.; Yu, M.; Shen, B.-f. 2002: IL-6 inhibits apoptosis of human myeloma cell line XG-7 through activation of JAK/STAT pathway and up-regulation of Mcl-1. Ai Zheng 21(2): 113-116
Grohmann, U.; Fallarino, F.; Bianchi, R.; Belladonna, M.L.; Vacca, C.; Orabona, C.; Uyttenhove, C.; Fioretti, M.C.; Puccetti, P. 2001: IL-6 inhibits the tolerogenic function of CD8 alpha+ dendritic cells expressing indoleamine 2,3-dioxygenase. Journal of Immunology 167(2): 708-714
Kurtiş, B.; Develioğlu, H.; Taner, I.L.; Baloş, K.; Tekin, I.O. 1999: IL-6 levels in gingival crevicular fluid (GCF) from patients with non-insulin dependent diabetes mellitus (NIDDM), adult periodontitis and healthy subjects. Journal of Oral Science 41(4): 163-167
Bitounis, D.; Barnier, V.; Guibert, C.; Pourchez, Jérémie.; Forest, Vérie.; Boudard, D.; Hochepied, J-François.; Chelle, P.; Vergnon, J-Michel.; Cottier, Mèle. 2018: A method for the quantitative extraction of gold nanoparticles from human bronchoalveolar lavage fluids through a glycerol gradient. Nanoscale 10(6): 2955-2969
Hokland, P.; Mikkelsen, P.; Segel, E. 1994: IL-6 might relieve long-standing thrombocytopenia in autotransplanted AML patients. British Journal of Haematology 87(4): 876-877
Parikh, A.A.; Salzman, A.L.; Kane, C.D.; Fischer, J.E.; Hasselgren, P.O. 1997: IL-6 production in human intestinal epithelial cells following stimulation with IL-1 beta is associated with activation of the transcription factor NF-kappa B. Journal of Surgical Research 69(1): 139-144
Gonzalez-Gay, M.A.; Hajeer, A.H.; Dababneh, A.; Garcia-Porrua, C.; Mattey, D.L.; Amoli, M.M.; Thomson, W.; Ollier, W.E.R. 2002: IL-6 promoter polymorphism at position -174 modulates the phenotypic expression of polymyalgia rheumatica in biopsy-proven giant cell arteritis. Clinical and Experimental Rheumatology 20(2): 179-184
Graf, M.R.; Prins, R.M.; Merchant, R.E. 2001: IL-6 secretion by a rat T9 glioma clone induces a neutrophil-dependent antitumor response with resultant cellular, antiglioma immunity. Journal of Immunology 166(1): 121-129
Barton, B.E.; Murphy, T.F.; Adem, P.; Watson, R.A.; Irwin, R.J.; Huang, H.F. 2001: IL-6 signaling by STAT3 participates in the change from hyperplasia to neoplasia in NRP-152 and NRP-154 rat prostatic epithelial cells. Bmc Cancer 1: 19
Puthier, D.; Bataille, R.; Amiot, M. 1999: IL-6 up-regulates mcl-1 in human myeloma cells through JAK / STAT rather than ras / MAP kinase pathway. European Journal of Immunology 29(12): 3945-3950
James, K.; Premchand, N.; Skibinska, A.; Skibinski, G.; Nicol, M.; Mason, J.I. 1997: IL-6, DHEA and the ageing process. Mechanisms of Ageing and Development 93(1-3): 15-24
Cao, Q.; Batey, R.; Pang, G.; Russell, A.; Clancy, R. 1998: IL-6, IFN-gamma and TNF-alpha production by liver-associated T cells and acute liver injury in rats administered concanavalin a. Immunology and Cell Biology 76(6): 542-549
Clavien, P.A. 1997: IL-6, a key cytokine in liver regeneration. Hepatology 25(5): 1294-1296
Alvino, S.; Marcucci, M.; Canzoniere, D.; Mosiello, A.; Del Monte, G.; Venturo, I.; Rinaldi, M.; Gandolfo, G.M.; Lopez, M.; Greco, C. 1999: IL-6, p53 and proto-oncogene c-myc play different roles as biological markers of plasma cell dyscrasias. La Clinica Terapeutica 150(3): 197-202
Murakami, M.; Hibi, M.; Nakagawa, N.; Nakagawa, T.; Yasukawa, K.; Yamanishi, K.; Taga, T.; Kishimoto, T. 1993: IL-6-induced homodimerization of gp130 and associated activation of a tyrosine kinase. Science 260(5115): 1808-1810
Akira, S. 1997: IL-6-regulated transcription factors. International Journal of Biochemistry and Cell Biology 29(12): 1401-1418
Levison, S.W.; Jiang, F.J.; Stoltzfus, O.K.; Ducceschi, M.H. 2000: IL-6-type cytokines enhance epidermal growth factor-stimulated astrocyte proliferation. Glia 32(3): 328-337
Kitazawa, H.; Muegge, K.; Badolato, R.; Wang, J.M.; Fogler, W.E.; Ferris, D.K.; Lee, C.K.; Candéias, S.; Smith, M.R.; Oppenheim, J.J.; Durum, S.K. 1997: IL-7 activates alpha4beta1 integrin in murine thymocytes. Journal of Immunology 159(5): 2259-2264
Tsark, E.C.; Dao, M.A.; Wang, X.; Weinberg, K.; Nolta, J.A. 2001: IL-7 enhances the responsiveness of human T cells that develop in the bone marrow of athymic mice. Journal of Immunology 166(1): 170-181
Toraldo, G.; Roggia, C.; Qian, W.-P.; Pacifici, R.; Weitzmann, M.N. 2003: IL-7 induces bone loss in vivo by induction of receptor activator of nuclear factor kappa B ligand and tumor necrosis factor alpha from T cells. Proceedings of the National Academy of Sciences of the United States of America 100(1): 125-130
Verhoeyen, E.; Dardalhon, V.; Ducrey-Rundquist, O.; Trono, D.; Taylor, N.; Cosset, F.ço.-L.ïc. 2003: IL-7 surface-engineered lentiviral vectors promote survival and efficient gene transfer in resting primary T lymphocytes. Blood 101(6): 2167-2174
Fry, T.J.; Moniuszko, M.; Creekmore, S.; Donohue, S.J.; Douek, D.C.; Giardina, S.; Hecht, T.T.; Hill, B.J.; Komschlies, K.; Tomaszewski, J.; Franchini, G.; Mackall, C.L. 2003: IL-7 therapy dramatically alters peripheral T-cell homeostasis in normal and SIV-infected nonhuman primates. Blood 101(6): 2294-2299
Okamoto, Y.; Douek, D.C.; McFarland, R.D.; Koup, R.A. 2002: IL-7, the thymus, and naïve T cells. Advances in Experimental Medicine and Biology 512: 81-90
Yu, C.; Liu, Y.; Peng, X. 2000: IL-8 and IL-10 levels in endometriosis and regulated role of neiyifang on them. Zhongguo Zhong Xi Yi Jie he Za Zhi Zhongguo Zhongxiyi Jiehe Zazhi 20(8): 603-605
Fredriksson, M.; Bergström, K.; Asman, B. 2002: IL-8 and TNF-alpha from peripheral neutrophils and acute-phase proteins in periodontitis. Journal of Clinical Periodontology 29(2): 123-128
Lango, R.; Anisimowicz, L.; Siebert, J.; Rogowski, J.; Bakowska, A.; Mroziński, P.; Narkiewicz, M. 2001: IL-8 concentration in coronary sinus blood during early coronary reperfusion after ischemic arrest. European Journal of Cardio-Thoracic Surgery: Official Journal of the European Association for Cardio-Thoracic Surgery 20(3): 550-554
Shi, Y.; Hui, Y.; Zhang, X.; Yang, K.; Yu, C. 1997: IL-8 in experimental proliferative vitreoretiopathy induced by macrophages. Yan Ke Xue Bao 13(2): 49-51; 66
Ceyhan, B.B.; Ozgün, S.; Celikel, T.; Yalçin, M.; Koç, M. 1996: IL-8 in pleural effusion. Respiratory Medicine 90(4): 215-221
Ulfman, L.H.; Joosten, D.P.; van der Linden, J.A.; Lammers, J.W.; Zwaginga, J.J.; Koenderman, L. 2001: IL-8 induces a transient arrest of rolling eosinophils on human endothelial cells. Journal of Immunology 166(1): 588-595
Miyamoto, K.; Matsukawa, A.; Ohkawara, S.; Takagi, K.; Yoshinaga, M. 1997: IL-8 is involved in homologous TNF alpha-, but not in IL-1 beta-induced neutrophil infiltration in rabbits. Inflammation Research: Official Journal of the European Histamine Research Society . 46(11): 472-477
Schadendorf; Möller; Algermissen; Worm; Sticherling; Czarnetzki 1994: IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor. Journal of Immunology 153(7): 3360
Mantas, C.; Direskeneli, H.; Oz, D.; Yavuz, S.; Akoglu, T. 2000: IL-8 producing cells in patients with Behçet's disease. Clinical and Experimental Rheumatology 18(2): 249-251
Smith, R.S.; Fedyk, E.R.; Springer, T.A.; Mukaida, N.; Iglewski, B.H.; Phipps, R.P. 2001: IL-8 production in human lung fibroblasts and epithelial cells activated by the Pseudomonas autoinducer N-3-oxododecanoyl homoserine lactone is transcriptionally regulated by NF-kappa B and activator protein-2. Journal of Immunology 167(1): 366-374
Linevsky, J.K.; Pothoulakis, C.; Keates, S.; Warny, M.; Keates, A.C.; Lamont, J.T.; Kelly, C.P. 1997: IL-8 release and neutrophil activation by Clostridium difficile toxin-exposed human monocytes. American Journal of Physiology 273(6): G1333-G1340
Fierer, J.; Eckmann, L.; Kagnoff, M. 1993: IL-8 secreted by epithelial cells invaded by bacteria. Infectious Agents and Disease 2(4): 255-258
Leong, S.R.; Lowman, H.B.; Liu, J.; Shire, S.; Deforge, L.E.; Gillece-Castro, B.L.; McDowell, R.; Hébert, C.A. 1997: IL-8 single-chain homodimers and heterodimers: interactions with chemokine receptors CXCR1, CXCR2, and DARC. Protein Science: a Publication of the Protein Society 6(3): 609-617
Antonelli, M.; Testa, G.; Tritapepe, L.; D'Errico, R.R.; Costa, D.; Giovannelli, L.; Riccioni, L.; Gasparetto, A.; Catena, G. 1999: IL-8, IL-6 and ICAM-1 in serum of paediatric patients undergoing cardiopulmonary bypass with and without cardiocirculatory arrest. Journal of Cardiovascular Surgery 40(6): 803-809
Stassen, M.; Müller, C.; Arnold, M.; Hültner, L.; Klein-Hessling, S.; Neudörfl, C.; Reineke, T.; Serfling, E.; Schmitt, E. 2001: IL-9 and IL-13 production by activated mast cells is strongly enhanced in the presence of lipopolysaccharide: NF-kappa B is decisively involved in the expression of IL-9. Journal of Immunology 166(7): 4391-4398
Hoyle, G.W.; Brody, A.R. 2001: IL-9 and lung fibrosis: a Th2 good guy?. American Journal of Respiratory Cell and Molecular Biology 24(4): 365-367
Grohmann, U.; Van Snick, J.; Campanile, F.; Silla, S.; Giampietri, A.; Vacca, C.; Renauld, J.C.; Fioretti, M.C.; Puccetti, P. 2000: IL-9 protects mice from Gram-negative bacterial shock: suppression of TNF-alpha, IL-12, and IFN-gamma, and induction of IL-10. Journal of Immunology 164(8): 4197-4203
Gibertini, M. 1996: IL1 beta impairs relational but not procedural rodent learning in a water maze task. Advances in Experimental Medicine and Biology 402: 207-217
Romani, L.; Bistoni, F.; Mencacci, A.; Cenci, E.; Spaccapelo, R.; Puccetti, P. 1995: IL12 in Candida albicans infections. Research in Immunology 146(7-8): 532-538
Tamura, K.; Fukuda, Y.; Sashio, H.; Takeda, N.; Bamba, H.; Kosaka, T.; Fukui, S.; Sawada, K.; Tamura, K.; Satomi, M.; Yamada, T.; Yamamura, T.; Yamamoto, Y.; Furuyama, J.-i.; Okamura, H.; Shimoyama, T. 2002: IL18 polymorphism is associated with an increased risk of Crohn's disease. Journal of Gastroenterology 37(Suppl 14): 111-116
Ammar, A.; Bertoli, A.M.; Chouaib, S.; Clemenceau, C.; Jasmin, C.; Georgoulias, V. 1993: IL2-R alpha chain inhibitory factor (p29) produced by HIV-infected macrophages: cell target and mode of action. Cellular Immunology 152(2): 358-370
Puck, J.M. 1996: IL2RGbase: a database of gamma c-chain defects causing human X-SCID. Immunology Today 17(11): 507-511
Rolling, C.; Treton, D.; Pellegrini, S.; Galanaud, P.; Richard, Y. 1996: IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells. Febs Letters 393(1): 53-56
Torres-Galván, M.J.; Quiralte, J.; Pestano, J.J.; Ortega, N.; Blanco, C.; Castillo, R.; Carrillo, T.; Pérez-Aciego, P.; Sánchez-García, F. 2001: IL4-R1 (5q31-q33) and FcepsilonRI-betaca (11q13) markers and atopy: a case/control study in a spanish population. Allergy 56(2): 159-163
Anonymous 1999: IL: six week femur rehab stay projected: patient deteriorates & dies in nursing home. Regan Report on Nursing Law 39(12): 3
Anonymous 2002: IL: surgeon 'drops scissors' in nurse's hand: glove punctured--suit brought by nurse. Nursing Law's Regan Report 43(1): 3
Gitelman, D.R. 2002: ILAB: a program for postexperimental eye movement analysis. Behavior Research Methods Instruments and Computers: a Journal of the Psychonomic Society Inc 34(4): 605-612
Anonymous 1997: ILAE Commission report. Restrictions for children with epilepsy. Commission of Pediatrics of the ILAE. International League Against Epilepsy. Epilepsia 38(9): 1054-1056
Reynolds, E.H. 2001: ILAE/IBE/WHO Global Campaign "out of the shadows": global and regional developments. Epilepsia 42(8): 1094-1100
Swofford, H.J.; Koertner, A.J.; Zemp, F.; Ausdemore, M.; Liu, A.; Salyards, M.J. 2018: A method for the statistical interpretation of friction ridge skin impression evidence: Method development and validation. Forensic Science International 287: 113-126
Spangler, A.; Wilson-Clay, B. 1997: ILCA, IBLCE, and LLLI: distinct missions define breastfeeding organizations. Journal of Human Lactation: Official Journal of International Lactation Consultant Association 13(4): 271-272
Chastain, R.M. 1993: ILCA's position paper statement on HIV. Journal of human lactation: official journal of International Lactation Consultant Association 9(2): 80-81
Spangler, A.; Wilson-Clay, B. 1997: ILCA, IBLCE, and LLLI: distinct missions define breastfeeding organizations. Journal of Human Lactation: Official Journal of International Lactation Consultant Association 13(4): 271-272
Spangler, A.K. 1996: ILCA: the past, the present, the future. Journal of Human Lactation: Official Journal of International Lactation Consultant Association 12(3): 268
Kattwinkel, J.; Niermeyer, S.; Nadkarni, V.; Tibballs, J.; Phillips, B.; Zideman, D.; Van Reempts, P.; Osmond, M. 1999: ILCOR advisory statement: resuscitation of the newly born infant. An advisory statement from the pediatric working group of the International Liaison Committee on Resuscitation. Circulation 99(14): 1927-1938
Genzwuerker, H.V.; Isovic, H.; Ellinger, K. 2002: ILCOR/ERC recommendations for out-of-hospital 12-lead ECG and fibrinolysis are not well adopted at present. Resuscitation 52(3): 305-306
Anonymous 2002: ILEX oncology acquires CD52 diagnostic rights for Campath. Expert Review of Molecular Diagnostics 2(6): 525-526
Kern, J.; Gamberger, D.; Sonicki, Z.; Vuletić, S. 1997: ILLM--inductive learning algorithm as a method for prediction of life expectancy achieving. Studies in Health Technology and Informatics 43 Pt B: 656-660
Anonymous 1982: ILO and its population information activities. POPIN bulletin 1982(2): 1-4
Anonymous 1977: ILO looks at possible methods of controlling world-wide social security health care costs. Employee Benefit Plan Review 31(11): 46-47
Grover, N. 2001: ILO recommends workers' compensation AIDS guidelines. Aids Policy and Law 16(14): 7
Hofer, M.; Shuker, L. 2000: ILSI Europe Workshop on Assessing Health Risks From Environmental Exposure to Chemicals: the Example of Drinking Water. Summary Report. International Life Sciences Institute. Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association 38(1 Suppl): S3-12
Solbé, J.; Holt, M.; Calow, P. 2001: ILSI Europe workshop on Assessing and Controlling Industrial Impacts on the Aquatic Environment: With Reference to Food Processing. International Life Sciences Institute. Ecotoxicology and Environmental Safety 50(2): 89-101
Rodrigo, C.P.; Van Praagh, E.; Gibney, M.; Sjöström, M. 1999: ILSI Europe workshop on Diet and Physical Activity--Interactions for Health: summary and conclusions. 22-24 March, 1999 in Chamonix, France. International Life Sciences Institute. Public Health Nutrition 2(3a): 321-325
Edwards, G.; Savva, S. 2001: ILSi Europe, the drinks industry, and a conflict of interest undeclared. Addiction 96(2): 197-202
Shatenstein, S. 2001: ILSi and the tobacco industry connection. Addiction 96(10): 1509-1510
Stanley, J. 2002: ILSI and the tobacco industry. International Life Sciences Institute. American Journal of Public Health 92(6): 891
Doll, R. 2001: ILSI: no attempt to influence. Addiction 96(10): 1510-1511
Smucny, J.J. 1997: IM diclofenac for biliary colic. Journal of Family Practice 45(4): 287-288
Dalton, E.; Dragg, L.; MacLean, S. 1996: IM injection volume limit. American Journal of Nursing 96(7): 13
Gladding, M. 1995: IM match continues upward trend in 1995. Internist 36(6): 16
Sobti, J.C. 1994: IMA Workshop on 'Medical Ethics and Ethos in Cases of Torture', IMA House, New Delhi, November 25-27, 1994. Journal of the Indian Medical Association 92(11): 385-388
Jolly, J.G. 1997: IMA and blood transfusion services in India. Journal of the Indian Medical Association 95(9): 490-491
Anonymous 1993: IMA to conduct training courses in family planning. Indian Medical Tribune 1(9): 2
Herijgers, P.; Flameng, W. 1997: IMA use in combined valve surgery and coronary artery bypass grafting. European Journal of Cardio-Thoracic Surgery: Official Journal of the European Association for Cardio-Thoracic Surgery 11(3): 594-595
Vanden Brink, J. 1991: IMACS support shift toward enhanced service. Diagnostic Imaging 13 Suppl: 11-16
Cariaso, M.; Folta, P.; Wagner, M.; Kuczmarski, T.; Lennon, G. 1999: IMAGEne I: clustering and ranking of I.M.A.G.E. cDNA clones corresponding to known genes. Bioinformatics 15(12): 965-973
Anonymous 1995: IMAP on emergency contraception. Statement developed by the International Medical Advisory Panel to IPPF (IMAP), 1994. EntreNous 1995(28-29): 19
Hern, W.M. 1993: Cervical treatment with Dilapan prior to second trimester dilation and evacuation abortion: a pilot study of 64 patients. American Journal of Gynecologic Health 7(1): 23-26
Wattenberg, B. 1994: A dramatic drop in human fertility. Sun 27(5): 25a
Kaztman, R. 1992: Why are men so irresponsible?. Cepal Review 28(46): 79-87
Howard, R.J.; Tuck, S.M. 1994: Contraception and sickle cell disease. Ippf Medical Bulletin 28(4): 3-4
Huezo, C. 1994: The quality of family planning services: a challenge for the 1990s. Ippf Medical Bulletin 28(6): 3-4
Singh, M.M. 1995: IUDs and transmigration -- putting an old concern to rest. Ippf Medical Bulletin 29(1): 2-3
Nowicka, W. 1993: Two steps back: Poland's new abortion law. Planned Parenthood in Europe 22(2): 18-20
Martín-Baranera, M.; Planas, I.; Palau, J.; Sanz, F. 1995: IMASIS computer-based medical record project: dealing with the human factor. Medinfo. Medinfo 8 Pt 1: 333
Sancho, J.J.; Planas, I.; Domènech, D.; Martín-Baranera, M.; Palau, J.; Sanz, F. 1998: IMASIS. a multicenter hospital information system--experience in Barcelona. Studies in Health Technology and Informatics 56: 35-42
Grover, N.K. 1993: IMC (Amendment) Ordinance 1992. Journal of the Indian Medical Association 91(8): 201
Borfitz, D. 1986: IMC "positive steps": limit members, expand plans. Home Health Journal 7(8): 3 6
Herbst, R.S.; Hong, W.K. 2002: IMC-C225, an anti-epidermal growth factor receptor monoclonal antibody for treatment of head and neck cancer. Seminars in Oncology 29(5 Suppl 14: 18-30
Anonymous 1977: IMCH to carry on - Del Mundo: continued POPCOM aid assured. Imch Newsletter 8(92): 1
Ghosh, S. 1999: IMCi strategy for India. Indian Pediatrics 36(11): 1178-1180
Hartmann, M.; Bogner, L.; Fippel, M.; Scherer, J.; Scherer, S. 2002: IMCO(++)--a Monte Carlo based IMRT system. Zeitschrift für Medizinische Physik 12(2): 97-108
Comins, D.L.; Brooks, C.A.; al-awar, R.S.; Goehring, R.R. 1999: IMDA/retro-Mannich approach to cis-perhydroquinoline Lycopodium alkaloids: asymmetric synthesis of (+)-luciduline. Organic Letters 1(2): 229-231
Anonymous 1997: IMED/IVAC IMED Gemini series general-purpose infusion pumps disabled by corrosion in protective circuit. Health Devices 26(5): 222
Becks, T. 2002: IMEX--a new knowledge platform for microsystems in medicine. Biomedizinische Technik. Biomedical Engineering 47 Suppl 1 Pt 2: 907-908
Anonymous 1994: IMF / World Bank boards of governors discuss population, migration. ICPD 94: newsletter of the International Conference on Population and Development 1994(15): 3
Denoon, D.J. 1995: IMF, World Bank programs hinder AIDS prevention. Aids Weekly 1995: 8-10
Tulgan, H.; Butorac, M.; McCue, J.D. 1997: IMG applicants to a medical residency program. Academic Medicine: Journal of the Association of American Medical Colleges 72(8): 659-660
Lefranc, M.P. 1998: IMGT (ImMunoGeneTics) locus on focus. A new section of Experimental and Clinical Immunogenetics. Experimental and Clinical Immunogenetics 15(1): 1-7
Lefranc, M.-P.; Pommié, C.; Ruiz, M.; Giudicelli, V.ér.; Foulquier, E.; Truong, L.; Thouvenin-Contet, V.ér.; Lefranc, G.ér. 2003: IMGT unique numbering for immunoglobulin and T cell receptor variable domains and Ig superfamily V-like domains. Developmental and Comparative Immunology 27(1): 55-77
Giudicelli, V.; Chaume, D.; Bodmer, J.; Müller, W.; Busin, C.; Marsh, S.; Bontrop, R.; Marc, L.; Malik, A.; Lefranc, M.P. 1997: IMGT, the international ImMunoGeneTics database. Nucleic Acids Research 25(1): 206-211
Giudicelli, V.; Chaume, D.; Mennessier, G.; Althaus, H.H.; Müller, W.; Bodmer, J.; Malik, A.; Lefranc, M.P. 1998: IMGT, the international ImMunoGeneTics database: a new design for immunogenetics data access. Studies in Health Technology and Informatics 52 Pt 1: 351-355
Robinson, J.; Waller, M.J.; Parham, P.; Bodmer, J.G.; Marsh, S.G. 2000: IMGT/HLA Database--a sequence database for the human major histocompatibility complex. Nucleic Acids Research 29(1): 210-213
Giudicelli, V.; Chaume, D.; Lefranc, M.P. 1998: IMGT/LIGM-DB: a systematized approach for ImMunoGeneTics database coherence and data distribution improvement. Proceedings. International Conference on Intelligent Systems for Molecular Biology 6: 59-68
Jaklevic, M.C. 1997: IMGs (international medical graduates) targeted. Residency slot cuts could hit foreign grads hardest. Modern Healthcare 27(8): 16
McClain, T.A. 1996: IMGs and cultural diversity training. Academic Medicine: Journal of the Association of American Medical Colleges 71(11): 1138-1139
Ward, R.D. 1997: IMGs set goals for AMA section. Michigan Medicine 96(6): 28-29
Rebuzzi, E.; Pannone, A.; Schiavetti, S.; Santoriello, P.; de Nicola, U.; Fancellu, G.; Cau, P.; Gulli, S.; Dordolin, P.; Maniscalco, P.; Morici, F.; Commessatti, M.; Pozzi-Mucelli, M.; Maiorana, C.S.; Bassini, F. 2002: IMHS clinical experience in the treatment of peritrochanteric fractures. the results of a multicentric Italian study of 981 cases. Injury 33(5): 407-412
Lorenzi, N.M. 1999: IMIA Working Group 13: organizational impact of medical informatics. International Journal of Medical Informatics 56(1-3): 5-8
Van Gennip, E.M. 1999: IMIA Working Group 15: technology assessment and quality development in health informatics. International Journal of Medical Informatics 56(1-3): 9-12
Goracci, G.; Mori, G.; Casa de' Martinis, L.; Bazzucchi, M. 1994: An ultrastructural analysis of dentin treated with chemical agents. Minerva Stomatologica 42(7-8): 313-325
Lober, W.B.; Trigg, L.J.; Bliss, D.; Brinkley, J.M. 2001: IML: An image markup language. Proceedings. AMIA Symposium 2001: 403-407
Miller, P.L.; Frawley, S.J.; Sayward, F.G.; Yasnoff, W.A.; Duncan, L.; Fleming, D.W. 1996: IMM/Serve: a rule-based program for childhood immunization. Proceedings: a Conference of the American Medical Informatics Association. AMIA Fall Symposium 1996: 184-188
Gebauer, G.; Rieger, M.; Jäger, W.; Lang, N. 1999: IMMULITE OM-MA assay: a useful diagnostic tool in patients with benign and malignant ovarian tumors. Anticancer Research 19(4a): 2535-2536
Maes, L.; Songa, E.B.; Hamers, R. 1993: IMOL 881, a new trypanocidal compound. Acta Tropica 54(3-4): 261-269
Nakamura, T.; Shibata, N.; Doi, Y.; Okuda, K.; Nakata, C.; Heijyo, H.; Matsuo, N.; Masuda, M.; Takahashi, H.; Arakawa, Y. 2002: IMP-1 type metalo-beta-lactamase producing Serratia marcescens strains isolated from blood culture between 1991 to 2000. Kansenshogaku Zasshi. Journal of the Japanese Association for Infectious Diseases 76(4): 246-253
Tylka, A.J.; Dietrich, W.F. 1999: IMP-8 observations of the spectra, composition, and variability of solar heavy ions at high energies relevant to manned space missions. Radiation Measurements 30(3): 345-359
Marques, A.F.; Teixeira, N.A.; Gambaretto, C.; Sillero, A.; Sillero, M.A. 1998: IMP-GMP 5'-nucleotidase from rat brain: activation by polyphosphates. Journal of Neurochemistry 71(3): 1241-1250
Quaratino, C.P.; Messina, E.; Arduini, A.; Angelini, G.; Spoto, G.; Gizzi, F.; Ruffini, I.; Odorisio, M.; Giacomello, A. 1998: IMP-dehydrogenase (IMPDH), hypoxanthine-guanine phosphoribosyltransferase (HGPRT), and phosphodiesterases (PDEs) expression during mycophenolic acid (MPA)-induced differentiation in human neuroblastoma cell lines. Advances in Experimental Medicine and Biology 431: 439-441
Griesmacher, A.; Weigel, G.; Seebacher, G.; Müller, M.M. 1997: IMP-dehydrogenase inhibition in human lymphocytes and lymphoblasts by mycophenolic acid and mycophenolic acid glucuronide. Clinical Chemistry 43(12): 2312-2317
Brotherton, B.G.; Babka, J.C. 1995: IMPACT CARE: a quality assessment tool that works. Journal for Healthcare Quality: Official Publication of the National Association for Healthcare Quality 17(2): 11-16
Anonymous 2002: IMPACT seeks breakthrough improvements in quality. Healthcare Benchmarks and Quality Improvement 1(2): 13-16
Lenert, L.A.; Michelson, D.; Flowers, C.; Bergen, M.R. 1995: IMPACT: an object-oriented graphical environment for construction of multimedia patient interviewing software. Proceedings. Symposium on Computer Applications in Medical Care 1995: 319-323
Williams, B. 2001: IMPACT: revitalizing TMA's political clout. Tennessee Medicine: Journal of the Tennessee Medical Association 94(5): 157-159
Schäffer, A.A.; Wolf, Y.I.; Ponting, C.P.; Koonin, E.V.; Aravind, L.; Altschul, S.F. 1999: IMPALA: matching a protein sequence against a collection of PSI-BLAST-constructed position-specific score matrices. Bioinformatics 15(12): 1000-1011
Magnan, S.; Solberg, L.I.; Kottke, T.E.; Nelson, A.F.; Amundson, G.M.; Richards, S.; Reed, M.K. 1998: IMPROVE: bridge over troubled waters. Joint Commission Journal on Quality Improvement 24(10): 566-578
Young, R.; Snyder, B. 2001: IMRT (intensity modulated radiation therapy): progress in technology and reimbursement. Radiology Management 23(6): 20-26; 28Quiz: 33-35
Clark, C.H.; Mubata, C.D.; Meehan, C.A.; Bidmead, A.M.; Staffurth, J.; Humphreys, M.E.; Dearnaley, D.P. 2002: IMRT clinical implementation: prostate and pelvic node irradiation using Helios and a 120-leaf multileaf collimator. Journal of Applied Clinical Medical Physics 3(4): 273-284
Cozzi, L.; Fogliata, A. 2002: IMRT in the treatment of head and neck cancer: is the present already the future?. Expert Review of Anticancer Therapy 2(3): 297-308
Snyder, B. 2002: IMRT update. Radiology Management 24(1): 13
Partridge, M.; Ebert, M.; Hesse, B.M. 2002: IMRT verification by three-dimensional dose reconstruction from portal beam measurements. Medical Physics 29(8): 1847-1858
Jack Yang, C.C.; Raben, A.; Carlson, D. 2001: IMRT: high-definition radiation therapy in a community hospital. Medical Dosimetry: Official Journal of the American Association of Medical Dosimetrists 26(2): 215-226
McCormack, J. 1995: IMS America drops Common Category Database project. Materials Management in Health Care 4(7): 14
Anonymous 1999: IMS health annual data show expanding pharmaceutical market growth--three-way tie for number one in global pharmaceutical sales. Biomedicine and PharmacoTherapy 53(5-6): 290-292
Askins, D.G. 1999: Common breast problems: detection and management. Journal of the South Carolina Medical Association 95(11): 415-419
Fiellin, D.A.; Feinstein, A.R. 1998: Bootstraps and jackknives: new, computer-intensive statistical tools that require no mathematical theories. Journal of Investigative Medicine: the Official Publication of the American Federation for Clinical Research 46(2): 22-26
Wax, C.M.; Abend, D.S.; Pearson, P.H. 1997: Chest pain and the role of somatic dysfunction. Journal of the American Osteopathic Association 97(6): 347-352; 355
Anonymous 2000: IMS to support Medicare lawsuit. Iowa medicine: journal of the Iowa Medical Society 90(1): 9
Tercha, L. 1994: IMS updates HMM med-surg price indexes. Hospital Material Dollar Sign Management 19(12): 13
Doyle, J.J. 1991: IMS updates HMM's med-surg indexes. Hospital Material Dollar Sign Management 16(2): 14-18
Doyle, J.J. 1991: IMS updates HMM's pharmacy indexes. Hospital Material Dollar Sign Management 16(1): 19-22
Koyama, T.; Endo, S.; Takei, H.; Hiekata, T. 1999: Recurrent cardiac tamponade treated using a pericardio-venous shunt. Japanese Journal of Thoracic and Cardiovascular Surgery: Official Publication of the Japanese Association for Thoracic Surgery 47(10): 506-509
Zhou, X.; Gan, Y.; Xiong, J.; Zhang, D.; Zhao, Q.; Xia, Z. 2018: A Method for Tooth Model Reconstruction Based on Integration of Multimodal Images. Journal of Healthcare Engineering 2018: 4950131
Spath, P. 1995: Is your quality planning tied to your Qi strategy?. Hospital Peer Review 20(3): 45-48
Arcamone, A. 1979: Lowered water temperatures heat bacteriostat controversy. Laundry News 5(8): 11
Patterson, M.K.; Bulard, R.A.; Larsen, C.; Rohrer, M.D. 1995: IMTEC implants: clinical evaluation of 120 patients: 548 implants. Journal - Oklahoma Dental Association 86(1): 12-15
Yost, L.G. 1977: IMV mount dismounted. Respiratory Care 22(2): 132 134
Fried, J.L. 1976: IMV versus assisted ventilation to eliminate work of breathing. Respiratory Care 21(11): 1080-1081
Willer, J.ür.; Noack, N.; Ellwanger, U.; Hoffmann, J.ür. 2002: IMZ implants in the treatment of the shortened dental arch in the upper and lower jaws. Schweizer Monatsschrift für Zahnmedizin 112(11): 1116-1120
Weibrich, G.; Gnoth, S.H.; Buch, R.S.; Müller, F.; Loos, A.H.; Wagner, W. 2001: IMZ-TwinPlus bone implant system--4 years clinical experience. Mund- Kiefer- und Gesichtschirurgie: Mkg 5(2): 120-125
Mabrut, J.Y.; Grandjean, J.P.; Henry, L.; Chappuis, J.P.; Partensky, C.; Barth, X.; Tissot, E. 2002: IMesenteric and mesocolic cystic lymphangiomas. Diagnostic and therapeutic management. Annales de Chirurgie 127(5): 343-349
Suresh, G. 1999: IMpact-RSV Study Group report. Pediatrics 104(4 Pt 1): 993; Author Reply 995
Kraft 1997: IMx (Abbott) Immunoassay of Insulin: a Practical Alternative to RIA Hyperinsulinemia Identification in Idiopathic Neurootology and other Hyperinsulin Metabolic Disorders. International Tinnitus Journal 3(2): 113-116
Fowler, J.M. 1999: The role of laparoscopic staging in the management of patients with early endometrial cancer. Gynecologic Oncology 73(1): 1-3
Block-Alper, L.; Webster, P.; Zhou, X.; Supeková, L.; Wong, W.H.; Schultz, P.G.; Meyer, D.I. 2002: IN02, a positive regulator of lipid biosynthesis, is essential for the formation of inducible membranes in yeast. Molecular Biology of the Cell 13(1): 40-51
Cloninger, K. 1997: City clinics threatened with privatization. Chart 94(7): 5
Blacker, S.; Chapman, K. 1997: Partnering to create patient education resources on breast cancer. Cancer Practice 6(2): 129-131
Ennen, K. 1997: INA house of delegates 74th Biennial Convention, October 23-25, 1997. Chart 94(12): 8-9
Trossman, S. 2000: INA nurses demand measures to combat workplace violence. American Nurse 32(1): 6; 9
Anonymous 1980: INA proposes HOPE--market-oriented health care program. Review - Federation of American Hospitals 13(3): 55-56
Miller, A.W. 1977: Management contracts aid hospitals and bolster growth of companies. Review - Federation of American Hospitals 10(5): 39-41
Kucera, J.; Havránek, V.; Smolík, J.; Schwarz, J.; Veselý, V.; Kugler, J.; Sýkorová, I.; Santroch, J. 1999: INAA and PIXE of atmospheric and combustion aerosols. Biological Trace Element Research 71-72: 233-245
Kvicala, J.; Jiránek, V. 1999: INAA of serum zinc of inhabitants in five regions of the Czech Republic. Biological Trace Element Research 71-72: 21-30
Arriola, H.; Longoria, L.; Quintero, A.; Guzman, D. 1999: INAA of trace elements in colorectal cancer patients. Biological Trace Element Research 71-72: 563-568
Verel, R.; van Beek, J.D.; Meier, B.H. 1999: INADEQUATE-CR experiments in the solid state. Journal of Magnetic Resonance 140(1): 300-303
Mu, Y.; Jiao, M.; Zhao, Y.; Lv, J.; Wang, J.; Hao, J.; Zhang, X.; Kong, Q.; Liu, Z. 2018: A method for tracing exogenous DNA uptake in live spermatozoa and embryos. Polish Journal of Veterinary Sciences 21(1): 193-202
Angelidis, P.; Anogianakis, G.; Maglavera, S. 1997: INCLUDE them all. Studies in Health Technology and Informatics 43 Pt B: 854-858
Piekorz; Hocke 1998: Induction of Differentiation by Il-6-Type Cytokines is Impaired in Myeloid Leukaemia cells Unable to Activate Stat5a. Cytokine 10(3): 240
Sakata, K.; Antonio, B.A.; Mukai, Y.; Nagasaki, H.; Sakai, Y.; Makino, K.; Sasaki, T. 2000: INE: a rice genome database with an integrated map view. Nucleic Acids Research 28(1): 97-101
Anonymous 2002: INEEL cleanup. Idaho National Engineering and Environmental Laboratory. Health Physics 83(2): 305-306
Kao; Grey 1998: INEPT experiments involving quadrupolar nuclei in solids. Journal of Magnetic Resonance 133(2): 313-323
Fusman; Zeltser; Rotstein; Chapman; Avitzour; Shapira; Eldor; Elkayam; Caspi; Arber; Berliner 2000: INFLAMET: an image analyzer to display erythrocyte adhesiveness/aggregation. European Journal of Internal Medicine 11(5): 271-276
Solovyev, V.V.; Salamov, A.A. 1999: INFOGENE: a database of known gene structures and predicted genes and proteins in sequences of genome sequencing projects. Nucleic Acids Research 27(1): 248-250
Brukner, I. 2001: INGN-201. Introgen Therapeutics. Current Opinion in Investigational Drugs 2(12): 1776-1785
Gopalkrishnan, R. 2002: INGN-241. Introgen. Current Opinion in Investigational Drugs 3(12): 1773-1777
Hayashi, A.; Shimura, A.; Uchiyama, H.; Nagao, K.; Kuriyama, T. 1993: INH preventive therapy in Chiba Prefecture--before and after the renewal of the guideline. Kekkaku: 68(6): 427-434
Hui, R.; Macmillan, R.D.; Kenny, F.S.; Musgrove, E.A.; Blamey, R.W.; Nicholson, R.I.; Robertson, J.F.; Sutherland, R.L. 2000: INK4a gene expression and methylation in primary breast cancer: overexpression of p16INK4a messenger RNA is a marker of poor prognosis. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 6(7): 2777-2787
Soussi, T.; Larsen, C.J.; Sigaux, F. 1999: INK4a-ARF (MTS1) or inhibitor of CDK-alternating reading frame (multiple tumor suppressor gene). Bulletin du Cancer 86(7-8): 605-607
Zindy, F.; van Deursen, J.; Grosveld, G.; Sherr, C.J.; Roussel, M.F. 2000: INK4d-deficient mice are fertile despite testicular atrophy. Molecular and Cellular Biology 20(1): 372-378
Citro, G.; Banks, G.; Cooper, G. 1997: INKBLOT: a neurological diagnostic decision support system integrating causal and anatomical knowledge. Artificial Intelligence in Medicine 10(3): 257-267
Menz, K.; Radomski, N.; Jost, E. 1996: INMP, a novel intranuclear matrix protein related to the family of intermediate filament-like proteins: molecular cloning and sequence analysis. Biochimica et Biophysica Acta 1309(1-2): 14-20
Hammond, C.L.; Romano, P.; Roe, S.; Tontonoz, P. 1993: INO2, a regulatory gene in yeast phospholipid biosynthesis, affects nuclear segregation and bud pattern formation. Cellular and Molecular Biology Research 39(6): 561-577
Acevedo, E.; Delgado, G.; Segil, E. 1998: INPPARES uses Internet to provide Peruvians with sexuality information and counseling. Siecus Report 26(5): 14
Aronow, D.B.; Ponte, J.M. 1994: INQUERY: inference net retrieval of encounter notes in an automated medical record. Proceedings. Symposium on Computer Applications in Medical Care 1994: 1049
Cembrowski, G.S.; Anderson, P.G.; Steeber, D.G.; Burnett, B.E. 1994: INR (International Normalized Ratio) reporting of prothrombin time. Mlo: Medical Laboratory Observer 26(5): 51-54
Wahl, M.J. 1996: INR and PTR anticoagulation values. Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontics 81(4): 377-378
Buchan, J. 2002: INR author speaks out: lack of data inhibits efforts to combat nursing shortages. International Nursing Review 49(4): 203
Boyd, M.R.; Powell, B.J.; Endicott, D.; Lewis, C.C. 2018: A Method for Tracking Implementation Strategies: An Exemplar Implementing Measurement-Based Care in Community Behavioral Health Clinics. Behavior Therapy 49(4): 525-537
Brigden, M.L.; Johnston, M.J. 1998: INR reporting in Canadian medical laboratories: an update. Thrombosis Interest Group of Canada. American Journal of Clinical Pathology 109(5): 589-594
Koertke, H.; Minami, K.; Bairaktaris, A.; Wagner, O.; Koerfer, R. 2000: INR self-management following mechanical heart valve replacement. Journal of Thrombosis and Thrombolysis 9(Suppl 1): S41-S45
Lidstone, V.; Janes, S.; Stross, P. 2000: INR: Intervals of measurement can safely extend to 14 weeks. Clinical and Laboratory Haematology 22(5): 291-293
Ahmed, S.; Bennett, S.T.; Huxtable, S.J.; Todd, J.A.; Matthews, D.R.; Gough, S.C. 1999: INS VNTR allelic variation and dynamic insulin secretion in healthy adult non-diabetic Caucasian subjects. Diabetic Medicine: a Journal of the British Diabetic Association 16(11): 910-917
Sautory, O. 1987: INSEE's permanent demographic sample. Revista. Centro de Estudos Demograficos 29: 141-168
Lazar, P. 1993: INSERM and research in neurosurgery. Neuro-Chirurgie 39(2): 72-74
Girot, R. 1996: INSERM clinical research network on sickle cell anemia: a tool for therapeutic care and research. Archives de Pediatrie: Organe Officiel de la Societe Francaise de Pediatrie 3(Suppl 1): 321s-323s
Eisinger, F.; Alby, N.; Bremond, A.; Dauplat, J.; Espié, M.; Janiaud, P.; Kuttenn, F.; Lebrun, J.P.; Lefranc, J.P.; Pierret, J.; Sobol, H.; Stoppa-Lyonnet, D.; Thouvenin, D.; Tristant, H.; Feingold, J. 1998: INSERM-FNCLCC collective expert's report. Recommendations for management of women having a genetic risk of developing breast and/or ovarian cancer. National Federation of Centers of the Fight Against Cancer. Annales d'Endocrinologie 59(6): 470-484
Eisinger, F.; Alby, N.; Bremond, A.; Dauplat, J.; Espié, M.; Janiaud, P.; Kuttenn, F.; Lebrun, J.P.; Lefranc, J.P.; Pierret, J.; Sobol, H.; Stoppa-Lyonnet, D.; Thouvenin, D.; Tristant, H.; Feingold, J. 1999: INSERM-FNCLCC collective expertise. Recommendations for medical management of women with genetic risk of developing breast and/or ovarian cancer. Annales de Genetique 42(1): 51-64
Iversen, P. 1993: INSERM/NIH Conference: antisense oligonucleotides and ribonucleases H, September, 1992. Antisense Research and Development 3(1): 83-85
Achard, J.M.; Oudart, N.; Aldigier, J.C. 2000: INSIGHT and NORDIL. International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment. Nordic Diltiazem Study. Lancet 356(9245): 1926-7; Author Reply 1928-9
Brown, M.J.; Castaigne, A.; Ruilope, L.M.; Mancia, G.; Rosenthal, T.; de Leeuw, P.W.; Ebner, F. 1996: INSIGHT: international nifedipine GITS study intervention as a goal in hypertension treatment. Journal of Human Hypertension 10 Suppl. 3: S157-S160
Schrader, W.T. 1993: INSIGHT: subunit functions of the steroid/thyroid receptor family. Molecular Endocrinology 7(10): 1241-1243
Minsky, B.D.; Pajak, T.F.; Ginsberg, R.J.; Pisansky, T.M.; Martenson, J.; Komaki, R.; Okawara, G.; Rosenthal, S.A.; Kelsen, D.P. 2002: INT 0123 (Radiation Therapy Oncology Group 94-05) phase IIi trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 20(5): 1167-1174
Hulsman, R.L.; Ros, W.J.; Janssen, M.; Winnubst, J.A. 1997: INTERACT-CANCER. The development and evaluation of a computer-assisted course on communication skills for medical specialists in oncology. Patient Education and Counseling 30(2): 129-141
Eilbeck, K.; Brass, A.; Paton, N.; Hodgman, C. 1999: INTERACT: an object oriented protein-protein interaction database. Proceedings. International Conference on Intelligent Systems for Molecular Biology 1999: 87-94
Carcich, T. 1978: INTERCARE and service. Journal-AmericanHealthCareAssociation 4(1): 53
Green, S. 1996: Positioning the patient for surgery. British Journal of Theatre Nursing: Natnews: the Official Journal of the National Association of Theatre Nurses 6(5): 35-38
Hamilton, N.ém.; Sabroe, I.; Renshaw, S.A. 2018: A method for transplantation of human HSCs into zebrafish, to replace humanised murine transplantation models. F1000research 7: 594
De Jonge, P.; Huyse, F.J.; Stiefel, F.C.; Slaets, J.P.; Gans, R.O. 2001: INTERMED--a clinical instrument for biopsychosocial assessment. Psychosomatics 42(2): 106-109
Huyse, F.J.; de Jonge, P.; Lyons, J.S.; Stiefel, F.C.; Slaets, J.P. 1999: INTERMED: a tool for controlling for confounding variables and designing multimodal treatment. Journal of Psychosomatic Research 46(4): 401-402
Torra i Bou, J.E. 1995: INTERNET (Y II). Aids to nursing. Revista de Enfermeria 18(208): 57-61
Schneider, D. 1993: INTERNET: linking nurses, scholars, libraries. Reflections 19(1): 9
Lawrence, S.V. 1978: INTERNIST: computer program expressing clinical experience and judgment of a master internist constitutes a unique resource. Forum on Medicine 1(1): 44-47
Cohen, J.; Carlet, J. 1996: INTERSEPT: an international, multicenter, placebo-controlled trial of monoclonal antibody to human tumor necrosis factor-alpha in patients with sepsis. International Sepsis Trial Study Group. Critical Care Medicine 24(9): 1431-1440
Small 1997: INTRODUCTION. Part 1: Connectionist Models of Lexical Processing. Brain and Language 59(1): 5-6
Demuth, C.; Winther-Larsen, A.; Madsen, A.T.; Meldgaard, P.; Sorensen, B.S. 2018: A method for treatment monitoring using circulating tumour DNA in cancer patients without targetable mutations. Oncotarget 9(57): 31066-31076
Duda, M. 1988: IOC rescinds ban on birth control drug. Physician and Sportsmedicine 16(2): 175 179
Nigg, B.M.; Saltin, B. 2002: IOC-Olympic Prize 2002. Journal of Electromyography and Kinesiology: Official Journal of the International Society of Electrophysiological Kinesiology 12(2): Iii
Beart, R.W.; Streeter, O.E. 1998: IOHDR brachytherapy in recurrent or metastatic colorectal carcinoma. Annals of Surgical Oncology 5(1): 2-3
Meuwissen, S.G.; Ewe, K.; Gassull, M.A.; Geboes, K.; Jewell, D.; Pallone, F.; Rachmilewitz, D.; Rask-Madsen, J.; Riddell, B.H.; Sandborn, B.J.; Schmuck, M.L. 2000: IOIBD questionnaire on the clinical use of azathioprine, 6-mercaptopurine, cyclosporin A and methotrexate in the treatment of inflammatory bowel diseases. European Journal of Gastroenterology and Hepatology 12(1): 13-18
Gunn, J. 1996: Review suctioning systems with an eye to cost containment. Hospital Material Dollar Sign Management 21(10): 18
Buonanni, D.; Swendrzynski, B. 1995: Supply distribution systems: ATMs of health care. Hospital Material Dollar Sign Management 20(12): 18-19
Anonymous 1999: IOL (intraocular lense) prices expected to decline next year. Hospital Material Dollar Sign Management 24(10): 1 13-1 15
Anonymous 1998: IOL (intraocular lenses) prices led by technology, payments. Hospital Material Dollar Sign Management 23(11): 1 14-1 15
Avins, L.R. 1997: IOL condensation. Ophthalmology 104(3): 343-344
Friederg, M.A.; Berler, D.K. 1994: IOL fixation techniques at keratoplasty. Ophthalmology 101(5): 797-8; author reply 799-800
Anonymous 1997: IOL prices level off after 3 years. Hospital Material Dollar Sign Management 22(11): 1 10